[{"data":1,"prerenderedAt":2039},["ShallowReactive",2],{"ki-studienmonitor-public-projection":3},{"schemaVersion":4,"datasetId":5,"generatedAt":6,"dateModified":7,"trackingSince":8,"materialFingerprint":9,"sourceFingerprint":10,"sourcePolicy":11,"claimBoundary":19,"collection":21,"counts":29,"studies":36,"evidence":1398,"events":1426,"lifecycle":1942,"methodology":1983,"dossierSlugs":1989,"downloads":2030},1,"i6eal.ki-studienmonitor-eu.v1","2026-08-12T02:29:00.000Z","2026-08-12","2026-07-23","809dbcff8b1974de687649eab5afa93a5b3314f5e3a7492211bb493a414a97a5","af3965a15574b11d08c3ab45daa8a4e3af91a18acc8f6975325295f3bad1d9d0",{"officialOnly":12,"source":13,"sourceOperator":14,"allowedHost":15,"identityRule":16,"evidenceRule":17,"privacyRule":18},true,"Clinical Trials Information System (CTIS) public retrieve API","European Medicines Agency","euclinicaltrials.eu","Exact EUCT number from the reviewed 20-study registry; no fuzzy entity matching.","Exact artificial intelligence, machine learning, deep learning or neural network phrase in an allowlisted public scientific field.","Only reviewed trial, application, country, status and exact evidence fields are retained. Raw records, sponsor\u002Fcontact names, addresses, telephone numbers and email addresses are never written.",{"medicinalClinicalTrialsOnly":12,"publicationCorpus":20,"fundingCorpus":20,"efficacyInferred":20,"complianceInferred":20,"causalInferenceUsed":20},false,{"mode":22,"completed":12,"exactSeedCount":23,"firstObservedAt":24,"lastObservedAt":6,"sourceLatestDate":25,"archiveRevision":26,"archiveMaterialHash":27,"archiveTransactionHash":28},"verified-official-api-archive",20,"2026-07-23T11:19:41.794Z","2026-08-05",21,"d8ede84f00a0a61144df8f445f6894e5a23c95bc8813b9918f5cb4ca27ce1eb2","fb317c3ab08e020187b951a85dc9672fd77e16098ed53f0b4450b55f5c35ac3e",{"studies":23,"authorised":30,"ended":31,"countries":32,"applications":33,"evidence":34,"officialEvents":35,"collectionChanges":31},18,2,11,59,27,234,[37,107,214,275,313,356,433,488,560,693,803,851,892,943,1036,1078,1173,1214,1267,1335],{"id":38,"euct":39,"title":40,"publicTitle":40,"fullTitle":41,"shortTitle":42,"status":43,"statusCode":44,"startDateEU":45,"decisionDate":46,"publishDate":47,"trialRegion":48,"trialRegionCode":49,"medicalConditions":50,"therapeuticAreas":53,"trialCategory":60,"duration":61,"countries":64,"applications":83,"evidence":97,"official":103,"slug":39,"firstObservedAt":24,"lastObservedAt":6,"dateModified":7,"materialFingerprint":106},"ctis:2026-525620-23-00","2026-525620-23-00","Local and Systemic Immune Modulation by Rilvegostomig in Advanced Gastric Cancer: The RILVE Project","Local and systemic immune modulation by Rilvegostomig (AZD2936) in the treatment of advanced gastric cancer (RILVE Project)","VHIO26001\u002FESR2523009","Authorised","2",null,"2026-07-22T10:55:01.733","2026-07-29T03:42:06.995509076","Both","3",[51],{"name":52,"rareDisease":20},"advanced gastric cancer",[54,57],{"code":55,"name":56},"6","Diseases [C] - Digestive System Diseases [C06]",{"code":58,"name":59},"4","Diseases [C] - Neoplasms [C04]",{"phaseCode":58,"categoryCode":44,"lowIntervention":20},{"estimatedRecruitmentStartDate":62,"estimatedEndDate":63,"estimatedGlobalEndDate":63},"2026-06-01","2030-06-01",[65],{"name":66,"publicStatusCode":44,"firstDecisionDate":46,"lastDecisionDate":46,"history":67},"Spain",[68,76,79],{"source":69,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":74,"date":75,"reportingStatusCode":43,"applicationStatusCode":43},"application_country_status","IN","INITIAL","authorized","acceptable","2026-07-20","2026-07-22",{"source":77,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":46,"isRMS":12},"application_decision","decision",{"source":77,"applicationBusinessKey":80,"applicationType":81,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45,"eventType":78,"date":82,"isRMS":12},"NSM-1","NON SUBSTANTIAL MODIFICATION","2026-07-28T13:12:22.067",[84,91],{"id":85,"businessKey":70,"type":71,"status":43,"trialStatus":43,"submissionDate":86,"decisionDate":75,"decisions":87,"countryStatuses":89},"application:2026-525620-23-00:in","2026-04-30",[88],{"mscName":66,"decisionDate":46,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":12},[90],{"countryName":66,"mscName":66,"trialStatus":43,"decision":72,"decisionDate":75,"firstDecisionDate":75,"assessmentOutcome":73,"assessmentOutcomeDate":74,"reportingStatusCode":43,"applicationStatusCode":43},{"id":92,"businessKey":80,"type":81,"status":43,"trialStatus":43,"submissionDate":93,"decisionDate":93,"decisions":94,"countryStatuses":96},"application:2026-525620-23-00:nsm-1","2026-07-28",[95],{"mscName":66,"decisionDate":82,"decision":72,"assessmentOutcome":45,"eventType":78,"applicationType":81,"isRMS":12},[],[98],{"id":99,"path":100,"term":101,"snippet":102},"evidence:c9c51035d7df7913aec02ce5","authorizedApplication.authorizedPartI.trialDetails.trialInformation.endPoint.secondaryEndPoints[4].endPoint","artificial intelligence","…expression and\u002For spatial distribution in the tumor microenvironment (eg, CD8, PD-L1, etc.) as measured by IHC and other assays including analytical methods (eg, digital pathology artificial intelligence).",{"retrieveUrl":104,"publicUrl":105},"https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public-api\u002Fretrieve\u002F2026-525620-23-00","https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public\u002Fview\u002F2026-525620-23-00?lang=en","4dca8fb1e9ab0040a140f540740fddb0dcd92c20ebd207a50a56d706d9b887f4",{"id":108,"euct":109,"title":110,"publicTitle":110,"fullTitle":110,"shortTitle":111,"status":43,"statusCode":49,"startDateEU":112,"decisionDate":113,"publishDate":114,"trialRegion":115,"trialRegionCode":116,"medicalConditions":117,"therapeuticAreas":120,"trialCategory":122,"duration":124,"countries":127,"applications":183,"evidence":205,"official":210,"slug":109,"firstObservedAt":24,"lastObservedAt":6,"dateModified":7,"materialFingerprint":213},"ctis:2023-505575-69-01","2023-505575-69-01","Fight Osteosarcoma Through European Research evolving study platform from diagnosis to relapse (FOSTER evolving study platform)","2025\u002F4106","2026-07-31","2026-07-08T11:46:28.691","2026-08-05T03:41:12.77854348","EEA","1",[118],{"name":119,"rareDisease":20},"Osteosarcoma",[121],{"code":58,"name":59},{"phaseCode":123,"categoryCode":44,"lowIntervention":20},"5",{"estimatedRecruitmentStartDate":125,"estimatedEndDate":126,"estimatedGlobalEndDate":45},"2026-07-06","2034-07-06",[128,138,144,152,157,163,170,176],{"name":129,"publicStatusCode":44,"firstDecisionDate":130,"lastDecisionDate":130,"history":131},"Denmark","2026-07-08T16:25:00.493",[132,137],{"source":69,"applicationBusinessKey":133,"applicationType":71,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"assessmentOutcomeDate":135,"date":136,"reportingStatusCode":43,"applicationStatusCode":43},"IN-1","authorized_conditions","2026-07-03","2026-07-08",{"source":77,"applicationBusinessKey":133,"applicationType":71,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"eventType":78,"date":130,"isRMS":20},{"name":139,"publicStatusCode":44,"firstDecisionDate":140,"lastDecisionDate":140,"history":141},"Finland","2026-07-08T13:41:38.471",[142,143],{"source":69,"applicationBusinessKey":133,"applicationType":71,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"assessmentOutcomeDate":125,"date":136,"reportingStatusCode":43,"applicationStatusCode":43},{"source":77,"applicationBusinessKey":133,"applicationType":71,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"eventType":78,"date":140,"isRMS":20},{"name":145,"publicStatusCode":49,"firstDecisionDate":146,"lastDecisionDate":146,"history":147},"France","2026-07-10T18:42:04.638",[148,151],{"source":69,"applicationBusinessKey":133,"applicationType":71,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"assessmentOutcomeDate":149,"date":150,"reportingStatusCode":43,"applicationStatusCode":43},"2026-06-30","2026-07-10",{"source":77,"applicationBusinessKey":133,"applicationType":71,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"eventType":78,"date":146,"isRMS":12},{"name":153,"publicStatusCode":44,"firstDecisionDate":113,"lastDecisionDate":113,"history":154},"Italy",[155,156],{"source":69,"applicationBusinessKey":133,"applicationType":71,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"assessmentOutcomeDate":125,"date":136,"reportingStatusCode":43,"applicationStatusCode":43},{"source":77,"applicationBusinessKey":133,"applicationType":71,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"eventType":78,"date":113,"isRMS":20},{"name":158,"publicStatusCode":44,"firstDecisionDate":159,"lastDecisionDate":159,"history":160},"Netherlands","2026-07-10T14:30:28.477",[161,162],{"source":69,"applicationBusinessKey":133,"applicationType":71,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"assessmentOutcomeDate":135,"date":150,"reportingStatusCode":43,"applicationStatusCode":43},{"source":77,"applicationBusinessKey":133,"applicationType":71,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"eventType":78,"date":159,"isRMS":20},{"name":164,"publicStatusCode":44,"firstDecisionDate":165,"lastDecisionDate":165,"history":166},"Poland","2026-07-13T16:10:09.734",[167,169],{"source":69,"applicationBusinessKey":133,"applicationType":71,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"assessmentOutcomeDate":125,"date":168,"reportingStatusCode":43,"applicationStatusCode":43},"2026-07-13",{"source":77,"applicationBusinessKey":133,"applicationType":71,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"eventType":78,"date":165,"isRMS":20},{"name":66,"publicStatusCode":44,"firstDecisionDate":171,"lastDecisionDate":171,"history":172},"2026-07-10T10:31:06.816",[173,175],{"source":69,"applicationBusinessKey":133,"applicationType":71,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"assessmentOutcomeDate":174,"date":150,"reportingStatusCode":43,"applicationStatusCode":43},"2026-07-01",{"source":77,"applicationBusinessKey":133,"applicationType":71,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"eventType":78,"date":171,"isRMS":20},{"name":177,"publicStatusCode":44,"firstDecisionDate":178,"lastDecisionDate":178,"history":179},"Sweden","2026-07-08T12:53:51.772",[180,182],{"source":69,"applicationBusinessKey":133,"applicationType":71,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"assessmentOutcomeDate":181,"date":136,"reportingStatusCode":43,"applicationStatusCode":43},"2026-06-18",{"source":77,"applicationBusinessKey":133,"applicationType":71,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"eventType":78,"date":178,"isRMS":20},[184],{"id":185,"businessKey":133,"type":71,"status":43,"trialStatus":43,"submissionDate":186,"decisionDate":136,"decisions":187,"countryStatuses":196},"application:2023-505575-69-01:in-1","2026-03-18",[188,189,190,191,192,193,194,195],{"mscName":153,"decisionDate":113,"decision":134,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":20},{"mscName":177,"decisionDate":178,"decision":134,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":20},{"mscName":139,"decisionDate":140,"decision":134,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":20},{"mscName":129,"decisionDate":130,"decision":134,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":20},{"mscName":66,"decisionDate":171,"decision":134,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":20},{"mscName":158,"decisionDate":159,"decision":134,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":20},{"mscName":145,"decisionDate":146,"decision":134,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":12},{"mscName":164,"decisionDate":165,"decision":134,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":20},[197,198,199,200,201,202,203,204],{"countryName":129,"mscName":129,"trialStatus":43,"decision":134,"decisionDate":136,"firstDecisionDate":136,"assessmentOutcome":73,"assessmentOutcomeDate":135,"reportingStatusCode":43,"applicationStatusCode":43},{"countryName":139,"mscName":139,"trialStatus":43,"decision":134,"decisionDate":136,"firstDecisionDate":136,"assessmentOutcome":73,"assessmentOutcomeDate":125,"reportingStatusCode":43,"applicationStatusCode":43},{"countryName":145,"mscName":145,"trialStatus":43,"decision":134,"decisionDate":150,"firstDecisionDate":150,"assessmentOutcome":73,"assessmentOutcomeDate":149,"reportingStatusCode":43,"applicationStatusCode":43},{"countryName":153,"mscName":153,"trialStatus":43,"decision":134,"decisionDate":136,"firstDecisionDate":136,"assessmentOutcome":73,"assessmentOutcomeDate":125,"reportingStatusCode":43,"applicationStatusCode":43},{"countryName":158,"mscName":158,"trialStatus":43,"decision":134,"decisionDate":150,"firstDecisionDate":150,"assessmentOutcome":73,"assessmentOutcomeDate":135,"reportingStatusCode":43,"applicationStatusCode":43},{"countryName":164,"mscName":164,"trialStatus":43,"decision":134,"decisionDate":168,"firstDecisionDate":168,"assessmentOutcome":73,"assessmentOutcomeDate":125,"reportingStatusCode":43,"applicationStatusCode":43},{"countryName":66,"mscName":66,"trialStatus":43,"decision":134,"decisionDate":150,"firstDecisionDate":150,"assessmentOutcome":73,"assessmentOutcomeDate":174,"reportingStatusCode":43,"applicationStatusCode":43},{"countryName":177,"mscName":177,"trialStatus":43,"decision":134,"decisionDate":136,"firstDecisionDate":136,"assessmentOutcome":73,"assessmentOutcomeDate":181,"reportingStatusCode":43,"applicationStatusCode":43},[206],{"id":207,"path":208,"term":101,"snippet":209},"evidence:3e8f26e02495804d11773809","authorizedApplication.authorizedPartI.trialDetails.trialInformation.trialObjective.secondaryObjectives[11].secondaryObjective","For FOSTER evolving study platform : To improve the characterization of lung nodules using artificial intelligence.",{"retrieveUrl":211,"publicUrl":212},"https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public-api\u002Fretrieve\u002F2023-505575-69-01","https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public\u002Fview\u002F2023-505575-69-01?lang=en","12f3d108994f43a23760304e8753d827482f676251bc38e94da35309ddeac26e",{"id":215,"euct":216,"title":217,"publicTitle":217,"fullTitle":218,"shortTitle":219,"status":43,"statusCode":58,"startDateEU":220,"decisionDate":221,"publishDate":222,"trialRegion":115,"trialRegionCode":116,"medicalConditions":223,"therapeuticAreas":236,"trialCategory":246,"duration":248,"countries":251,"applications":258,"evidence":266,"official":271,"slug":216,"firstObservedAt":24,"lastObservedAt":6,"dateModified":8,"materialFingerprint":274},"ctis:2025-523264-21-00","2025-523264-21-00","CIRAANO: Multimodal exploration of theater actors, memory athletes, and patients with various memory pathologies: evaluation of mnesic strategies and their cerebral substrates, and contribution to the treatment of memory pathologies.","CIRAANO: Multimodal exploration (including radiopharmaceuticals Amyvid® and Tauvid®) of theater actors, memory athletes, and patients with various memory pathologies: evaluation of mnesic strategies and their cerebral substrates, and contribution to the treatment of memory pathologies.","C24-50","2026-06-04","2026-01-23T18:35:27.022","2026-06-06T03:31:05.205799916",[224,226,228,230,232,234],{"name":225,"rareDisease":20},"Semantic Variant Primary Progressive Aphasia",{"name":227,"rareDisease":20},"Alcohol Use Disorder",{"name":229,"rareDisease":20},"Organic amnesia syndrome",{"name":231,"rareDisease":20},"Narcolepsy",{"name":233,"rareDisease":20},"Alzheimer",{"name":235,"rareDisease":20},"Lewy Body Dementia",[237,240,243],{"code":238,"name":239},"33","Psychiatry and Psychology [F] - Mental Disorders [F03]",{"code":241,"name":242},"28","Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]",{"code":244,"name":245},"23","Diseases [C] - Pathological Conditions, Signs and Symptoms [C23]",{"phaseCode":247,"categoryCode":44,"lowIntervention":20},"10",{"estimatedRecruitmentStartDate":249,"estimatedEndDate":250,"estimatedGlobalEndDate":45},"2025-11-01","2036-03-01",[252],{"name":145,"publicStatusCode":58,"firstDecisionDate":221,"lastDecisionDate":221,"history":253},[254,257],{"source":69,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":255,"date":256,"reportingStatusCode":43,"applicationStatusCode":43},"2026-01-20","2026-01-23",{"source":77,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":221,"isRMS":12},[259],{"id":260,"businessKey":70,"type":71,"status":43,"trialStatus":43,"submissionDate":261,"decisionDate":256,"decisions":262,"countryStatuses":264},"application:2025-523264-21-00:in","2025-10-10",[263],{"mscName":145,"decisionDate":221,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":12},[265],{"countryName":145,"mscName":145,"trialStatus":43,"decision":72,"decisionDate":256,"firstDecisionDate":256,"assessmentOutcome":73,"assessmentOutcomeDate":255,"reportingStatusCode":43,"applicationStatusCode":43},[267],{"id":268,"path":269,"term":101,"snippet":270},"evidence:d5488b0ee193ad32eca17e4e","authorizedApplication.authorizedPartI.trialDetails.trialInformation.trialObjective.secondaryObjectives[5].secondaryObjective","…pography of brain pathology and the factors influencing its propagation over 10 to 20 years, in both controls and patients, with the aim of predicting disease progression using an artificial intelligence model",{"retrieveUrl":272,"publicUrl":273},"https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public-api\u002Fretrieve\u002F2025-523264-21-00","https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public\u002Fview\u002F2025-523264-21-00?lang=en","a58198435949de886372040d2e74783c3db3384f8ecc166810f715c52c45cc32",{"id":276,"euct":277,"title":278,"publicTitle":278,"fullTitle":278,"shortTitle":45,"status":43,"statusCode":44,"startDateEU":45,"decisionDate":279,"publishDate":280,"trialRegion":115,"trialRegionCode":116,"medicalConditions":281,"therapeuticAreas":284,"trialCategory":286,"duration":287,"countries":289,"applications":296,"evidence":304,"official":309,"slug":277,"firstObservedAt":24,"lastObservedAt":6,"dateModified":8,"materialFingerprint":312},"ctis:2025-521385-10-00","2025-521385-10-00","ENDO-67 project: Investigating ENDOcrine therapy-related questions using Ki67 changes in the window-of-opportunity before breast surgery","2025-10-21T10:58:52.882","2025-10-22T03:31:39.101141607",[282],{"name":283,"rareDisease":20},"Breast cancer",[285],{"code":58,"name":59},{"phaseCode":55,"categoryCode":49,"lowIntervention":12},{"estimatedRecruitmentStartDate":249,"estimatedEndDate":288,"estimatedGlobalEndDate":45},"2030-11-01",[290],{"name":158,"publicStatusCode":44,"firstDecisionDate":279,"lastDecisionDate":279,"history":291},[292,295],{"source":69,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":293,"date":294,"reportingStatusCode":43,"applicationStatusCode":43},"2025-10-20","2025-10-21",{"source":77,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":279,"isRMS":12},[297],{"id":298,"businessKey":70,"type":71,"status":43,"trialStatus":43,"submissionDate":299,"decisionDate":294,"decisions":300,"countryStatuses":302},"application:2025-521385-10-00:in","2025-07-09",[301],{"mscName":158,"decisionDate":279,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":12},[303],{"countryName":158,"mscName":158,"trialStatus":43,"decision":72,"decisionDate":294,"firstDecisionDate":294,"assessmentOutcome":73,"assessmentOutcomeDate":293,"reportingStatusCode":43,"applicationStatusCode":43},[305],{"id":306,"path":307,"term":101,"snippet":308},"evidence:f6f9c3faffda39dcbc921626","authorizedApplication.authorizedPartI.trialDetails.trialInformation.trialObjective.secondaryObjectives[2].secondaryObjective","What is the concordance between Ki67 percentage measured by the pathologist versus an artificial intelligence (AI) algorithm",{"retrieveUrl":310,"publicUrl":311},"https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public-api\u002Fretrieve\u002F2025-521385-10-00","https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public\u002Fview\u002F2025-521385-10-00?lang=en","90e43cd1a9333245a02465b59f5e93be05f1696b2e567bc1906b36c085212195",{"id":314,"euct":315,"title":316,"publicTitle":316,"fullTitle":317,"shortTitle":45,"status":43,"statusCode":58,"startDateEU":318,"decisionDate":319,"publishDate":320,"trialRegion":115,"trialRegionCode":116,"medicalConditions":321,"therapeuticAreas":324,"trialCategory":328,"duration":329,"countries":332,"applications":340,"evidence":348,"official":352,"slug":315,"firstObservedAt":24,"lastObservedAt":6,"dateModified":8,"materialFingerprint":355},"ctis:2024-518482-99-01","2024-518482-99-01","Treatment of neovascular AMD: Artificial intelligence in real-world setting","Personalized treatment aided by automated analysis of fluid in active neovascular age-related macular degeneration (nAMD) in a prospective, multicenter, randomized study","2020-11-16","2025-01-15T20:23:56.001","2025-07-09T03:35:38.997601662",[322],{"name":323,"rareDisease":20},"neovasclar AMD",[325],{"code":326,"name":327},"11","Diseases [C] - Eye Diseases [C11]",{"phaseCode":55,"categoryCode":49,"lowIntervention":20},{"estimatedRecruitmentStartDate":330,"estimatedEndDate":331,"estimatedGlobalEndDate":45},"2020-04-14","2025-08-28",[333],{"name":334,"publicStatusCode":58,"firstDecisionDate":319,"lastDecisionDate":319,"history":335},"Austria",[336,339],{"source":69,"applicationBusinessKey":133,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":337,"date":338,"reportingStatusCode":43,"applicationStatusCode":43},"2024-12-10","2025-01-15",{"source":77,"applicationBusinessKey":133,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":319,"isRMS":12},[341],{"id":342,"businessKey":133,"type":71,"status":43,"trialStatus":43,"submissionDate":343,"decisionDate":338,"decisions":344,"countryStatuses":346},"application:2024-518482-99-01:in-1","2024-11-06",[345],{"mscName":334,"decisionDate":319,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":12},[347],{"countryName":334,"mscName":334,"trialStatus":43,"decision":72,"decisionDate":338,"firstDecisionDate":338,"assessmentOutcome":73,"assessmentOutcomeDate":337,"reportingStatusCode":43,"applicationStatusCode":43},[349],{"id":350,"path":351,"term":101,"snippet":316},"evidence:142ce486b513cf5a3df09694","authorizedApplication.authorizedPartI.trialDetails.clinicalTrialIdentifiers.publicTitle",{"retrieveUrl":353,"publicUrl":354},"https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public-api\u002Fretrieve\u002F2024-518482-99-01","https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public\u002Fview\u002F2024-518482-99-01?lang=en","5e73f590571b3f0ac5824c9c768d8aef0998c06348264237885ba818155df714",{"id":357,"euct":358,"title":359,"publicTitle":359,"fullTitle":360,"shortTitle":361,"status":43,"statusCode":58,"startDateEU":362,"decisionDate":363,"publishDate":364,"trialRegion":115,"trialRegionCode":116,"medicalConditions":365,"therapeuticAreas":368,"trialCategory":372,"duration":373,"countries":376,"applications":394,"evidence":418,"official":429,"slug":358,"firstObservedAt":24,"lastObservedAt":6,"dateModified":8,"materialFingerprint":432},"ctis:2024-510718-34-00","2024-510718-34-00","Study of Artificial Intelligence-based Personalized Rituximab Treatment Protocol in Membranous nephropathy - iRITUX","Study of Artificial Intelligence-based Personalized Rituximab Treatment Protocol in Membranous nephropathy","22-APN-01","2024-11-29","2024-09-09T17:19:59.143","2026-02-21T02:41:51.898069591",[366],{"name":367,"rareDisease":12},"Membranous nephropathy",[369],{"code":370,"name":371},"25","Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutics [E02]",{"phaseCode":326,"categoryCode":49,"lowIntervention":12},{"estimatedRecruitmentStartDate":374,"estimatedEndDate":375,"estimatedGlobalEndDate":45},"2024-10-01","2031-10-01",[377],{"name":145,"publicStatusCode":58,"firstDecisionDate":363,"lastDecisionDate":378,"history":379},"2026-02-20T12:22:06.411",[380,383,387,390,391,393],{"source":69,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":381,"date":382,"reportingStatusCode":43,"applicationStatusCode":43},"2024-09-04","2024-09-09",{"source":69,"applicationBusinessKey":384,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":386,"date":382,"reportingStatusCode":43,"applicationStatusCode":43},"SM-1","SUBSTANTIAL MODIFICATION","2025-03-03",{"source":69,"applicationBusinessKey":388,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":389,"date":382,"reportingStatusCode":43,"applicationStatusCode":43},"SM-2","2026-02-19",{"source":77,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":363,"isRMS":12},{"source":77,"applicationBusinessKey":384,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":392,"isRMS":12},"2025-04-18T15:58:15.69",{"source":77,"applicationBusinessKey":388,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":378,"isRMS":12},[395,402,410],{"id":396,"businessKey":70,"type":71,"status":43,"trialStatus":43,"submissionDate":397,"decisionDate":382,"decisions":398,"countryStatuses":400},"application:2024-510718-34-00:in","2024-05-27",[399],{"mscName":145,"decisionDate":363,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":12},[401],{"countryName":145,"mscName":145,"trialStatus":43,"decision":72,"decisionDate":382,"firstDecisionDate":382,"assessmentOutcome":73,"assessmentOutcomeDate":381,"reportingStatusCode":43,"applicationStatusCode":43},{"id":403,"businessKey":384,"type":385,"status":43,"trialStatus":43,"submissionDate":404,"decisionDate":405,"decisions":406,"countryStatuses":408},"application:2024-510718-34-00:sm-1","2025-01-24","2025-04-18",[407],{"mscName":145,"decisionDate":392,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[409],{"countryName":145,"mscName":145,"trialStatus":43,"decision":72,"decisionDate":382,"firstDecisionDate":382,"assessmentOutcome":73,"assessmentOutcomeDate":386,"reportingStatusCode":43,"applicationStatusCode":43},{"id":411,"businessKey":388,"type":385,"status":43,"trialStatus":43,"submissionDate":412,"decisionDate":413,"decisions":414,"countryStatuses":416},"application:2024-510718-34-00:sm-2","2026-01-16","2026-02-20",[415],{"mscName":145,"decisionDate":378,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[417],{"countryName":145,"mscName":145,"trialStatus":43,"decision":72,"decisionDate":382,"firstDecisionDate":382,"assessmentOutcome":73,"assessmentOutcomeDate":389,"reportingStatusCode":43,"applicationStatusCode":43},[419,422,424],{"id":420,"path":421,"term":101,"snippet":360},"evidence:3862a741cf7770f248b5c832","authorizedApplication.authorizedPartI.trialDetails.clinicalTrialIdentifiers.fullTitle",{"id":423,"path":351,"term":101,"snippet":359},"evidence:b6ed0fdf098036f64c8eedf9",{"id":425,"path":426,"term":427,"snippet":428},"evidence:276431009326b811ce77ccf5","authorizedApplication.authorizedPartI.trialDetails.trialInformation.trialObjective.secondaryObjectives[14].secondaryObjective","machine learning","Model improvement through machine learning",{"retrieveUrl":430,"publicUrl":431},"https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public-api\u002Fretrieve\u002F2024-510718-34-00","https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public\u002Fview\u002F2024-510718-34-00?lang=en","90f596a038213900c68072b7f9b59dacb1b2eb9cdd395ad87d2b7dafef47ac78",{"id":434,"euct":435,"title":436,"publicTitle":436,"fullTitle":437,"shortTitle":438,"status":43,"statusCode":58,"startDateEU":439,"decisionDate":440,"publishDate":441,"trialRegion":115,"trialRegionCode":116,"medicalConditions":442,"therapeuticAreas":445,"trialCategory":447,"duration":448,"countries":451,"applications":462,"evidence":477,"official":484,"slug":435,"firstObservedAt":24,"lastObservedAt":6,"dateModified":8,"materialFingerprint":487},"ctis:2024-510707-11-00","2024-510707-11-00","Artificial Intelligence driven personalisation of radiotherapy and concomitant androgen deprivation therapy for prostate cancer patients","Prostate-only, dose-escalated radiotherapy plus concomitant androgen deprivation therapy in primary localized, NCCN high risk and MMAI classifier low or intermediate-risk prostate cancer – a prospective, single-arm, phase II study","HypoPro","2024-10-21","2024-05-29T11:18:13.203","2025-10-07T04:07:02.521736825",[443],{"name":444,"rareDisease":20},"Prostate cancer",[446],{"code":58,"name":59},{"phaseCode":58,"categoryCode":49,"lowIntervention":12},{"estimatedRecruitmentStartDate":449,"estimatedEndDate":450,"estimatedGlobalEndDate":45},"2024-03-01","2026-09-30",[452],{"name":453,"publicStatusCode":58,"firstDecisionDate":440,"lastDecisionDate":454,"history":455},"Cyprus","2025-02-26T09:32:47.109",[456,458,460,461],{"source":69,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":397,"date":457,"reportingStatusCode":43,"applicationStatusCode":43},"2024-05-29",{"source":69,"applicationBusinessKey":388,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":459,"date":457,"reportingStatusCode":43,"applicationStatusCode":43},"2025-02-26",{"source":77,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":440,"isRMS":12},{"source":77,"applicationBusinessKey":388,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":454,"isRMS":12},[463,470],{"id":464,"businessKey":70,"type":71,"status":43,"trialStatus":43,"submissionDate":465,"decisionDate":457,"decisions":466,"countryStatuses":468},"application:2024-510707-11-00:in","2024-02-13",[467],{"mscName":453,"decisionDate":440,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":12},[469],{"countryName":453,"mscName":453,"trialStatus":43,"decision":72,"decisionDate":457,"firstDecisionDate":457,"assessmentOutcome":73,"assessmentOutcomeDate":397,"reportingStatusCode":43,"applicationStatusCode":43},{"id":471,"businessKey":388,"type":385,"status":43,"trialStatus":43,"submissionDate":472,"decisionDate":459,"decisions":473,"countryStatuses":475},"application:2024-510707-11-00:sm-2","2025-01-07",[474],{"mscName":453,"decisionDate":454,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[476],{"countryName":453,"mscName":453,"trialStatus":43,"decision":72,"decisionDate":457,"firstDecisionDate":457,"assessmentOutcome":73,"assessmentOutcomeDate":459,"reportingStatusCode":43,"applicationStatusCode":43},[478,480],{"id":479,"path":351,"term":101,"snippet":436},"evidence:cec585a404e599f9b0a77ba0",{"id":481,"path":482,"term":101,"snippet":483},"evidence:1fd58ea0ade90becc7866e8b","authorizedApplication.authorizedPartI.trialDetails.trialInformation.trialObjective.mainObjective","The individualization of radiotherapy (RT) based on prostate-specific membrane antigen positron emission tomography \u002F computed tomography (PSMA PET\u002FCT) imaging and a multimodal artificial intelligence (MMAI) system in terms de-intensification of hormonal therapy in parallel to ultra-hypofractionated RT and dose escalation to the prostate has no decreased disease-free survival.…",{"retrieveUrl":485,"publicUrl":486},"https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public-api\u002Fretrieve\u002F2024-510707-11-00","https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public\u002Fview\u002F2024-510707-11-00?lang=en","55e43d7d7a130be3f3de561fbe19a99e7ab704897b3eb762fcff0cffc4810f5b",{"id":489,"euct":490,"title":491,"publicTitle":491,"fullTitle":492,"shortTitle":45,"status":43,"statusCode":58,"startDateEU":493,"decisionDate":494,"publishDate":495,"trialRegion":115,"trialRegionCode":116,"medicalConditions":496,"therapeuticAreas":499,"trialCategory":502,"duration":503,"countries":506,"applications":522,"evidence":551,"official":556,"slug":490,"firstObservedAt":24,"lastObservedAt":6,"dateModified":8,"materialFingerprint":559},"ctis:2023-505430-10-00","2023-505430-10-00","TAP-TAU","The clinical value of tau PET in the memory clinic (TAP-TAU)","2024-10-10","2023-12-21T10:38:44.655","2026-03-19T02:32:08.844353511",[497],{"name":498,"rareDisease":20},"Mild cognitive impairment and dementia",[500],{"code":247,"name":501},"Diseases [C] - Nervous System Diseases [C10]",{"phaseCode":247,"categoryCode":44,"lowIntervention":20},{"estimatedRecruitmentStartDate":504,"estimatedEndDate":505,"estimatedGlobalEndDate":45},"2023-12-01","2026-12-01",[507],{"name":158,"publicStatusCode":58,"firstDecisionDate":494,"lastDecisionDate":508,"history":509},"2026-03-18T10:39:37.263",[510,512,514,516,517,519,521],{"source":69,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"assessmentOutcomeDate":511,"date":511,"reportingStatusCode":43,"applicationStatusCode":43},"2023-12-21",{"source":69,"applicationBusinessKey":388,"applicationType":385,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"assessmentOutcomeDate":513,"date":511,"reportingStatusCode":43,"applicationStatusCode":43},"2025-04-08",{"source":69,"applicationBusinessKey":515,"applicationType":385,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"assessmentOutcomeDate":186,"date":511,"reportingStatusCode":43,"applicationStatusCode":43},"SM-4",{"source":77,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"eventType":78,"date":494,"isRMS":12},{"source":77,"applicationBusinessKey":384,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45,"eventType":78,"date":518,"isRMS":12},"2024-09-06T15:40:06.292",{"source":77,"applicationBusinessKey":388,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":520,"isRMS":12},"2025-04-08T16:00:10.524",{"source":77,"applicationBusinessKey":515,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":508,"isRMS":12},[523,530,537,544],{"id":524,"businessKey":70,"type":71,"status":43,"trialStatus":43,"submissionDate":525,"decisionDate":511,"decisions":526,"countryStatuses":528},"application:2023-505430-10-00:in","2023-09-12",[527],{"mscName":158,"decisionDate":494,"decision":134,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":12},[529],{"countryName":158,"mscName":158,"trialStatus":43,"decision":134,"decisionDate":511,"firstDecisionDate":511,"assessmentOutcome":73,"assessmentOutcomeDate":511,"reportingStatusCode":43,"applicationStatusCode":43},{"id":531,"businessKey":384,"type":385,"status":43,"trialStatus":43,"submissionDate":532,"decisionDate":533,"decisions":534,"countryStatuses":536},"application:2023-505430-10-00:sm-1","2024-07-08","2024-09-06",[535],{"mscName":158,"decisionDate":518,"decision":72,"assessmentOutcome":45,"eventType":78,"applicationType":385,"isRMS":12},[],{"id":538,"businessKey":388,"type":385,"status":43,"trialStatus":43,"submissionDate":539,"decisionDate":513,"decisions":540,"countryStatuses":542},"application:2023-505430-10-00:sm-2","2025-01-29",[541],{"mscName":158,"decisionDate":520,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[543],{"countryName":158,"mscName":158,"trialStatus":43,"decision":134,"decisionDate":511,"firstDecisionDate":511,"assessmentOutcome":73,"assessmentOutcomeDate":513,"reportingStatusCode":43,"applicationStatusCode":43},{"id":545,"businessKey":515,"type":385,"status":43,"trialStatus":43,"submissionDate":546,"decisionDate":186,"decisions":547,"countryStatuses":549},"application:2023-505430-10-00:sm-4","2026-03-06",[548],{"mscName":158,"decisionDate":508,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[550],{"countryName":158,"mscName":158,"trialStatus":43,"decision":134,"decisionDate":511,"firstDecisionDate":511,"assessmentOutcome":73,"assessmentOutcomeDate":186,"reportingStatusCode":43,"applicationStatusCode":43},[552],{"id":553,"path":554,"term":101,"snippet":555},"evidence:43f8a8127de3964fa5bb2578","authorizedApplication.authorizedPartI.trialDetails.trialInformation.endPoint.secondaryEndPoints[0].endPoint","Performance of tau PET compared to novel blood-based biomarkers and artificial intelligence (AI) based classifiers.",{"retrieveUrl":557,"publicUrl":558},"https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public-api\u002Fretrieve\u002F2023-505430-10-00","https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public\u002Fview\u002F2023-505430-10-00?lang=en","a0f73bd5933023c914b9650bcacec9fb23dc8cfb353c45a11dc5cc0ab4616921",{"id":561,"euct":562,"title":563,"publicTitle":563,"fullTitle":564,"shortTitle":565,"status":566,"statusCode":567,"startDateEU":568,"decisionDate":569,"publishDate":570,"trialRegion":115,"trialRegionCode":116,"medicalConditions":571,"therapeuticAreas":574,"trialCategory":576,"duration":577,"countries":580,"applications":619,"evidence":680,"official":689,"slug":562,"firstObservedAt":24,"lastObservedAt":6,"dateModified":8,"materialFingerprint":692},"ctis:2022-502338-20-00","2022-502338-20-00","HU-F-AIM - A prospective, interventional clinical study to evaluate hydroxyurea (HU) resistance in patients with polycythaemia vera who meet prediction parameters identified in the PV-AIM project using artificial intelligence","HU-F-AIM - A prospective, interventional study to evaluate HU-resistance in polycythemia vera patients who meet predictive parameters identified in the machine learning project PV-AIM","CINC424BDE15","Ended","8","2023-07-28","2023-05-17T07:05:32.275","2026-03-05T02:38:57.993945354",[572],{"name":573,"rareDisease":12},"Polycythemia vera",[575],{"code":58,"name":59},{"phaseCode":55,"categoryCode":49,"lowIntervention":20},{"estimatedRecruitmentStartDate":578,"estimatedEndDate":579,"estimatedGlobalEndDate":45},"2023-05-01","2025-10-31",[581],{"name":582,"publicStatusCode":567,"firstDecisionDate":569,"lastDecisionDate":583,"history":584},"Germany","2025-09-11T10:27:15.661",[585,589,591,593,596,598,601,604,605,607,609,611,613,616,618],{"source":69,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":586,"assessmentOutcomeDate":587,"date":588,"reportingStatusCode":566,"applicationStatusCode":43},"no_conclusion","2023-05-15","2023-05-17",{"source":69,"applicationBusinessKey":384,"applicationType":385,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":590,"date":588,"reportingStatusCode":566,"applicationStatusCode":43},"2023-07-06",{"source":69,"applicationBusinessKey":388,"applicationType":385,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":592,"date":588,"reportingStatusCode":566,"applicationStatusCode":43},"2023-11-13",{"source":69,"applicationBusinessKey":594,"applicationType":385,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":595,"date":588,"reportingStatusCode":566,"applicationStatusCode":43},"SM-3","2024-04-26",{"source":69,"applicationBusinessKey":515,"applicationType":385,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":597,"date":588,"reportingStatusCode":566,"applicationStatusCode":43},"2024-11-05",{"source":69,"applicationBusinessKey":599,"applicationType":385,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":600,"date":588,"reportingStatusCode":566,"applicationStatusCode":43},"SM-5","2025-03-13",{"source":69,"applicationBusinessKey":602,"applicationType":385,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":603,"date":588,"reportingStatusCode":566,"applicationStatusCode":43},"SM-6","2025-09-10",{"source":77,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":586,"eventType":78,"date":569,"isRMS":12},{"source":77,"applicationBusinessKey":384,"applicationType":385,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73,"eventType":78,"date":606,"isRMS":12},"2023-07-07T10:17:04.418",{"source":77,"applicationBusinessKey":388,"applicationType":385,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73,"eventType":78,"date":608,"isRMS":12},"2023-11-14T13:03:45.234",{"source":77,"applicationBusinessKey":594,"applicationType":385,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73,"eventType":78,"date":610,"isRMS":12},"2024-04-29T11:13:31.269",{"source":77,"applicationBusinessKey":515,"applicationType":385,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73,"eventType":78,"date":612,"isRMS":12},"2024-11-06T10:50:13.228",{"source":77,"applicationBusinessKey":614,"applicationType":81,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":45,"eventType":78,"date":615,"isRMS":12},"NSM-3","2025-01-27T17:55:11.89",{"source":77,"applicationBusinessKey":599,"applicationType":385,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73,"eventType":78,"date":617,"isRMS":12},"2025-03-14T12:09:12.88",{"source":77,"applicationBusinessKey":602,"applicationType":385,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73,"eventType":78,"date":583,"isRMS":12},[620,627,635,643,651,658,664,672],{"id":621,"businessKey":70,"type":71,"status":43,"trialStatus":566,"submissionDate":622,"decisionDate":588,"decisions":623,"countryStatuses":625},"application:2022-502338-20-00:in","2023-02-14",[624],{"mscName":582,"decisionDate":569,"decision":72,"assessmentOutcome":586,"eventType":78,"applicationType":71,"isRMS":12},[626],{"countryName":582,"mscName":582,"trialStatus":566,"decision":72,"decisionDate":588,"firstDecisionDate":588,"assessmentOutcome":586,"assessmentOutcomeDate":587,"reportingStatusCode":566,"applicationStatusCode":43},{"id":628,"businessKey":384,"type":385,"status":43,"trialStatus":566,"submissionDate":629,"decisionDate":630,"decisions":631,"countryStatuses":633},"application:2022-502338-20-00:sm-1","2023-05-31","2023-07-07",[632],{"mscName":582,"decisionDate":606,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[634],{"countryName":582,"mscName":582,"trialStatus":566,"decision":72,"decisionDate":588,"firstDecisionDate":588,"assessmentOutcome":73,"assessmentOutcomeDate":590,"reportingStatusCode":566,"applicationStatusCode":43},{"id":636,"businessKey":388,"type":385,"status":43,"trialStatus":566,"submissionDate":637,"decisionDate":638,"decisions":639,"countryStatuses":641},"application:2022-502338-20-00:sm-2","2023-10-16","2023-11-14",[640],{"mscName":582,"decisionDate":608,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[642],{"countryName":582,"mscName":582,"trialStatus":566,"decision":72,"decisionDate":588,"firstDecisionDate":588,"assessmentOutcome":73,"assessmentOutcomeDate":592,"reportingStatusCode":566,"applicationStatusCode":43},{"id":644,"businessKey":594,"type":385,"status":43,"trialStatus":566,"submissionDate":645,"decisionDate":646,"decisions":647,"countryStatuses":649},"application:2022-502338-20-00:sm-3","2024-03-19","2024-04-29",[648],{"mscName":582,"decisionDate":610,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[650],{"countryName":582,"mscName":582,"trialStatus":566,"decision":72,"decisionDate":588,"firstDecisionDate":588,"assessmentOutcome":73,"assessmentOutcomeDate":595,"reportingStatusCode":566,"applicationStatusCode":43},{"id":652,"businessKey":515,"type":385,"status":43,"trialStatus":566,"submissionDate":653,"decisionDate":343,"decisions":654,"countryStatuses":656},"application:2022-502338-20-00:sm-4","2024-10-24",[655],{"mscName":582,"decisionDate":612,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[657],{"countryName":582,"mscName":582,"trialStatus":566,"decision":72,"decisionDate":588,"firstDecisionDate":588,"assessmentOutcome":73,"assessmentOutcomeDate":597,"reportingStatusCode":566,"applicationStatusCode":43},{"id":659,"businessKey":614,"type":81,"status":43,"trialStatus":566,"submissionDate":660,"decisionDate":660,"decisions":661,"countryStatuses":663},"application:2022-502338-20-00:nsm-3","2025-01-27",[662],{"mscName":582,"decisionDate":615,"decision":72,"assessmentOutcome":45,"eventType":78,"applicationType":81,"isRMS":12},[],{"id":665,"businessKey":599,"type":385,"status":43,"trialStatus":566,"submissionDate":666,"decisionDate":667,"decisions":668,"countryStatuses":670},"application:2022-502338-20-00:sm-5","2025-02-19","2025-03-14",[669],{"mscName":582,"decisionDate":617,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[671],{"countryName":582,"mscName":582,"trialStatus":566,"decision":72,"decisionDate":588,"firstDecisionDate":588,"assessmentOutcome":73,"assessmentOutcomeDate":600,"reportingStatusCode":566,"applicationStatusCode":43},{"id":673,"businessKey":602,"type":385,"status":43,"trialStatus":566,"submissionDate":674,"decisionDate":675,"decisions":676,"countryStatuses":678},"application:2022-502338-20-00:sm-6","2025-08-07","2025-09-11",[677],{"mscName":582,"decisionDate":583,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[679],{"countryName":582,"mscName":582,"trialStatus":566,"decision":72,"decisionDate":588,"firstDecisionDate":588,"assessmentOutcome":73,"assessmentOutcomeDate":603,"reportingStatusCode":566,"applicationStatusCode":43},[681,683,686],{"id":682,"path":421,"term":427,"snippet":564},"evidence:7a442b56438a02b0de9083a4",{"id":684,"path":351,"term":101,"snippet":685},"evidence:9d1357e7d7847532a9b50fa0","…ve, interventional clinical study to evaluate hydroxyurea (HU) resistance in patients with polycythaemia vera who meet prediction parameters identified in the PV-AIM project using artificial intelligence",{"id":687,"path":482,"term":427,"snippet":688},"evidence:e6c122c325710c6ee5433dd3","Evaluation of HU-resistance\u002Fintolerance in PV patients who meet the predictive risk factors identified in the machine learning project PV-AIM (referred to as: PV-AIM HU-resistance predictors) at start of their regular HU-treatment.",{"retrieveUrl":690,"publicUrl":691},"https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public-api\u002Fretrieve\u002F2022-502338-20-00","https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public\u002Fview\u002F2022-502338-20-00?lang=en","59a994d63ea5a84bd1a85f22e5063ffad83b0a93f4e5aafdf93e142dd0182294",{"id":694,"euct":695,"title":696,"publicTitle":696,"fullTitle":696,"shortTitle":697,"status":43,"statusCode":58,"startDateEU":374,"decisionDate":698,"publishDate":699,"trialRegion":115,"trialRegionCode":116,"medicalConditions":700,"therapeuticAreas":703,"trialCategory":705,"duration":706,"countries":708,"applications":738,"evidence":791,"official":799,"slug":695,"firstObservedAt":24,"lastObservedAt":6,"dateModified":8,"materialFingerprint":802},"ctis:2022-500596-32-00","2022-500596-32-00","Effect of xenon on brain injury, neurological outcome and survival in patients after aneurysmal subarachnoid hemorrhage","T109\u002F2019Xe-SAH","2022-06-22T13:44:32.4","2025-12-03T02:32:30.801653802",[701],{"name":702,"rareDisease":20},"Aneyrysmal subarachnoid hemorrhage needing ventilatory care in intensive care unit",[704],{"code":247,"name":501},{"phaseCode":58,"categoryCode":44,"lowIntervention":20},{"estimatedRecruitmentStartDate":374,"estimatedEndDate":707,"estimatedGlobalEndDate":45},"2035-12-01",[709],{"name":139,"publicStatusCode":58,"firstDecisionDate":698,"lastDecisionDate":710,"history":711},"2025-04-02T14:07:06.425",[712,715,716,719,720,722,725,726,728,730,732,734,735],{"source":69,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":713,"date":714,"reportingStatusCode":43,"applicationStatusCode":43},"2022-06-16","2022-06-22",{"source":69,"applicationBusinessKey":80,"applicationType":81,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45,"assessmentOutcomeDate":45,"date":714,"reportingStatusCode":43,"applicationStatusCode":43},{"source":69,"applicationBusinessKey":384,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":717,"assessmentOutcomeDate":718,"date":714,"reportingStatusCode":43,"applicationStatusCode":43},"acceptable_conditions","2023-05-25",{"source":69,"applicationBusinessKey":594,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45,"assessmentOutcomeDate":45,"date":714,"reportingStatusCode":43,"applicationStatusCode":43},{"source":69,"applicationBusinessKey":602,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":721,"date":714,"reportingStatusCode":43,"applicationStatusCode":43},"2024-09-16",{"source":69,"applicationBusinessKey":723,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":724,"date":714,"reportingStatusCode":43,"applicationStatusCode":43},"SM-7","2025-03-28",{"source":77,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":698,"isRMS":12},{"source":77,"applicationBusinessKey":384,"applicationType":385,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":717,"eventType":78,"date":727,"isRMS":12},"2023-06-06T13:21:43.039",{"source":77,"applicationBusinessKey":80,"applicationType":81,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45,"eventType":78,"date":729,"isRMS":12},"2023-11-30T11:18:02.106",{"source":77,"applicationBusinessKey":594,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45,"eventType":78,"date":731,"isRMS":12},"2024-06-05T15:04:52.676",{"source":77,"applicationBusinessKey":602,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":733,"isRMS":12},"2024-09-30T08:18:24.482",{"source":77,"applicationBusinessKey":723,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":710,"isRMS":12},{"source":77,"applicationBusinessKey":736,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45,"eventType":78,"date":737,"isRMS":12},"SM-8","2025-12-02T12:27:20.307",[739,746,754,761,769,777,785],{"id":740,"businessKey":70,"type":71,"status":43,"trialStatus":43,"submissionDate":741,"decisionDate":714,"decisions":742,"countryStatuses":744},"application:2022-500596-32-00:in","2022-05-30",[743],{"mscName":139,"decisionDate":698,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":12},[745],{"countryName":139,"mscName":139,"trialStatus":43,"decision":72,"decisionDate":714,"firstDecisionDate":714,"assessmentOutcome":73,"assessmentOutcomeDate":713,"reportingStatusCode":43,"applicationStatusCode":43},{"id":747,"businessKey":384,"type":385,"status":43,"trialStatus":43,"submissionDate":748,"decisionDate":749,"decisions":750,"countryStatuses":752},"application:2022-500596-32-00:sm-1","2023-03-14","2023-06-06",[751],{"mscName":139,"decisionDate":727,"decision":134,"assessmentOutcome":717,"eventType":78,"applicationType":385,"isRMS":12},[753],{"countryName":139,"mscName":139,"trialStatus":43,"decision":72,"decisionDate":714,"firstDecisionDate":714,"assessmentOutcome":717,"assessmentOutcomeDate":718,"reportingStatusCode":43,"applicationStatusCode":43},{"id":755,"businessKey":80,"type":81,"status":43,"trialStatus":43,"submissionDate":756,"decisionDate":756,"decisions":757,"countryStatuses":759},"application:2022-500596-32-00:nsm-1","2023-11-30",[758],{"mscName":139,"decisionDate":729,"decision":72,"assessmentOutcome":45,"eventType":78,"applicationType":81,"isRMS":12},[760],{"countryName":139,"mscName":139,"trialStatus":43,"decision":72,"decisionDate":714,"firstDecisionDate":714,"assessmentOutcome":45,"assessmentOutcomeDate":45,"reportingStatusCode":43,"applicationStatusCode":43},{"id":762,"businessKey":594,"type":385,"status":43,"trialStatus":43,"submissionDate":763,"decisionDate":764,"decisions":765,"countryStatuses":767},"application:2022-500596-32-00:sm-3","2024-05-28","2024-06-05",[766],{"mscName":139,"decisionDate":731,"decision":72,"assessmentOutcome":45,"eventType":78,"applicationType":385,"isRMS":12},[768],{"countryName":139,"mscName":139,"trialStatus":43,"decision":72,"decisionDate":714,"firstDecisionDate":714,"assessmentOutcome":45,"assessmentOutcomeDate":45,"reportingStatusCode":43,"applicationStatusCode":43},{"id":770,"businessKey":602,"type":385,"status":43,"trialStatus":43,"submissionDate":771,"decisionDate":772,"decisions":773,"countryStatuses":775},"application:2022-500596-32-00:sm-6","2024-08-21","2024-09-30",[774],{"mscName":139,"decisionDate":733,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[776],{"countryName":139,"mscName":139,"trialStatus":43,"decision":72,"decisionDate":714,"firstDecisionDate":714,"assessmentOutcome":73,"assessmentOutcomeDate":721,"reportingStatusCode":43,"applicationStatusCode":43},{"id":778,"businessKey":723,"type":385,"status":43,"trialStatus":43,"submissionDate":779,"decisionDate":780,"decisions":781,"countryStatuses":783},"application:2022-500596-32-00:sm-7","2025-03-06","2025-04-02",[782],{"mscName":139,"decisionDate":710,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[784],{"countryName":139,"mscName":139,"trialStatus":43,"decision":72,"decisionDate":714,"firstDecisionDate":714,"assessmentOutcome":73,"assessmentOutcomeDate":724,"reportingStatusCode":43,"applicationStatusCode":43},{"id":786,"businessKey":736,"type":385,"status":43,"trialStatus":43,"submissionDate":579,"decisionDate":787,"decisions":788,"countryStatuses":790},"application:2022-500596-32-00:sm-8","2025-12-02",[789],{"mscName":139,"decisionDate":737,"decision":72,"assessmentOutcome":45,"eventType":78,"applicationType":385,"isRMS":12},[],[792,796],{"id":793,"path":794,"term":101,"snippet":795},"evidence:9385ccca5a68b4da2b1c7706","authorizedApplication.authorizedPartI.trialDetails.trialInformation.endPoint.secondaryEndPoints[9].endPoint","Development of prognostication models with a selected combination of brain imaging, biomarkers, clinical data and metabolomics by applying artificial intelligence and machine learning for EBI within first 72 hours after start of aSAH symptoms , vasospasm (within 21 days after start of SAH symptoms) and DCI (between day 4 and 6 weeks after s…",{"id":797,"path":794,"term":427,"snippet":798},"evidence:5accde062ef252e0ae2f8abc","Development of prognostication models with a selected combination of brain imaging, biomarkers, clinical data and metabolomics by applying artificial intelligence and machine learning for EBI within first 72 hours after start of aSAH symptoms , vasospasm (within 21 days after start of SAH symptoms) and DCI (between day 4 and 6 weeks after start of SAH symptoms…",{"retrieveUrl":800,"publicUrl":801},"https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public-api\u002Fretrieve\u002F2022-500596-32-00","https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public\u002Fview\u002F2022-500596-32-00?lang=en","e62fb8176272d0d18bac1d35bef85c184a0c6e1c968e9560cac466ed2bb6e453",{"id":804,"euct":805,"title":806,"publicTitle":806,"fullTitle":806,"shortTitle":45,"status":43,"statusCode":58,"startDateEU":807,"decisionDate":808,"publishDate":809,"trialRegion":115,"trialRegionCode":116,"medicalConditions":810,"therapeuticAreas":813,"trialCategory":815,"duration":816,"countries":819,"applications":829,"evidence":843,"official":847,"slug":805,"firstObservedAt":24,"lastObservedAt":6,"dateModified":8,"materialFingerprint":850},"ctis:2024-520288-15-00","2024-520288-15-00","RAXO trial - A population-based prospective study to evaluate clinical behaviour, resectability and survival in metastatic colorectal cancer patients in Finland","2025-01-25","2025-01-24T12:17:33.004","2025-12-20T02:42:01.549903918",[811],{"name":812,"rareDisease":20},"Metastatic or locally advanced inoperable colorectal cancer",[814],{"code":58,"name":59},{"phaseCode":55,"categoryCode":49,"lowIntervention":12},{"estimatedRecruitmentStartDate":817,"estimatedEndDate":818,"estimatedGlobalEndDate":45},"2011-09-12","2035-12-31",[820],{"name":139,"publicStatusCode":58,"firstDecisionDate":808,"lastDecisionDate":821,"history":822},"2025-12-19T10:50:00.614",[823,825,827,828],{"source":69,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":824,"date":404,"reportingStatusCode":43,"applicationStatusCode":43},"2025-01-22",{"source":69,"applicationBusinessKey":384,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":826,"date":404,"reportingStatusCode":43,"applicationStatusCode":43},"2025-12-12",{"source":77,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":808,"isRMS":12},{"source":77,"applicationBusinessKey":384,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":821,"isRMS":12},[830,836],{"id":831,"businessKey":70,"type":71,"status":43,"trialStatus":43,"submissionDate":472,"decisionDate":404,"decisions":832,"countryStatuses":834},"application:2024-520288-15-00:in",[833],{"mscName":139,"decisionDate":808,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":12},[835],{"countryName":139,"mscName":139,"trialStatus":43,"decision":72,"decisionDate":404,"firstDecisionDate":404,"assessmentOutcome":73,"assessmentOutcomeDate":824,"reportingStatusCode":43,"applicationStatusCode":43},{"id":837,"businessKey":384,"type":385,"status":43,"trialStatus":43,"submissionDate":249,"decisionDate":838,"decisions":839,"countryStatuses":841},"application:2024-520288-15-00:sm-1","2025-12-19",[840],{"mscName":139,"decisionDate":821,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[842],{"countryName":139,"mscName":139,"trialStatus":43,"decision":72,"decisionDate":404,"firstDecisionDate":404,"assessmentOutcome":73,"assessmentOutcomeDate":826,"reportingStatusCode":43,"applicationStatusCode":43},[844],{"id":845,"path":307,"term":427,"snippet":846},"evidence:fb77564ec782d2bedf71ccbb","• To radiologically or with machine learning from scans or reports assess tumour sites ,density and morphology, and assess alternative radiologic response evaluation in comparison with RECIST response criteria",{"retrieveUrl":848,"publicUrl":849},"https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public-api\u002Fretrieve\u002F2024-520288-15-00","https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public\u002Fview\u002F2024-520288-15-00?lang=en","fe6cd1a730192ff00af92e5bccb9cc1fcdf8a866601ae38ca33484d7295ad3b0",{"id":852,"euct":853,"title":854,"publicTitle":854,"fullTitle":855,"shortTitle":856,"status":43,"statusCode":123,"startDateEU":857,"decisionDate":858,"publishDate":859,"trialRegion":115,"trialRegionCode":116,"medicalConditions":860,"therapeuticAreas":863,"trialCategory":865,"duration":866,"countries":868,"applications":875,"evidence":883,"official":888,"slug":853,"firstObservedAt":24,"lastObservedAt":6,"dateModified":8,"materialFingerprint":891},"ctis:2024-518494-34-00","2024-518494-34-00","Clinical trial conducted to evaluate the effectiveness of a combination of drugs called venetoclax and rituximab adapted to the state of minimal residual disease in patients with untreated chronic lymphocytic leukemia","A prospective, multicenter, phase II trial to assess the efficacy and safety of MRD-driven treatment with VEnetoclax and RItuximab combination in previously unTreated pAtients with chronic lymphocytic leukemia (VERITA PALG-CLL5 study)","VERITA PALG-CLL5","2022-02-24","2024-12-02T15:06:42.686","2024-12-03T02:09:26.760320031",[861],{"name":862,"rareDisease":20},"Chronic lymphocytic leukemia",[864],{"code":58,"name":59},{"phaseCode":58,"categoryCode":44,"lowIntervention":20},{"estimatedRecruitmentStartDate":857,"estimatedEndDate":867,"estimatedGlobalEndDate":45},"2027-07-31",[869],{"name":164,"publicStatusCode":123,"firstDecisionDate":858,"lastDecisionDate":858,"history":870},[871,874],{"source":69,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":872,"date":873,"reportingStatusCode":43,"applicationStatusCode":43},"2024-11-28","2024-12-02",{"source":77,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":858,"isRMS":12},[876],{"id":877,"businessKey":70,"type":71,"status":43,"trialStatus":43,"submissionDate":878,"decisionDate":873,"decisions":879,"countryStatuses":881},"application:2024-518494-34-00:in","2024-10-08",[880],{"mscName":164,"decisionDate":858,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":12},[882],{"countryName":164,"mscName":164,"trialStatus":43,"decision":72,"decisionDate":873,"firstDecisionDate":873,"assessmentOutcome":73,"assessmentOutcomeDate":872,"reportingStatusCode":43,"applicationStatusCode":43},[884],{"id":885,"path":886,"term":427,"snippet":887},"evidence:3fa258989f45d97cdcb7d57c","authorizedApplication.authorizedPartI.trialDetails.trialInformation.endPoint.secondaryEndPoints[8].endPoint","To develop innovative, machine-learning-based algorithms to assess the prediction of response to VR treatment in CLL (as a probability of selected categories of response supported by rationale) based on patients’ electr…",{"retrieveUrl":889,"publicUrl":890},"https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public-api\u002Fretrieve\u002F2024-518494-34-00","https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public\u002Fview\u002F2024-518494-34-00?lang=en","b6ccd757e5c047477baa6c78e790ecd68881dd40e8974446de13bd8725d264b5",{"id":893,"euct":894,"title":895,"publicTitle":895,"fullTitle":896,"shortTitle":897,"status":43,"statusCode":58,"startDateEU":898,"decisionDate":899,"publishDate":900,"trialRegion":115,"trialRegionCode":116,"medicalConditions":901,"therapeuticAreas":904,"trialCategory":908,"duration":909,"countries":911,"applications":919,"evidence":934,"official":939,"slug":894,"firstObservedAt":24,"lastObservedAt":6,"dateModified":8,"materialFingerprint":942},"ctis:2024-516022-63-00","2024-516022-63-00","Innovative Imaging and Cognitive BIOmarkers to Predict Huntington's Disease Progression","I2BIO-HD. Innovative Imaging and cognitive BIOmarkers to predict Huntington’s Disease progression","APHP210360","2024-03-21","2024-11-06T17:16:25.757","2025-09-18T03:52:54.731432746",[902],{"name":903,"rareDisease":12},"Patients with symptomatic and pre-symptomatic Huntington's disease",[905],{"code":906,"name":907},"16","Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]",{"phaseCode":123,"categoryCode":44,"lowIntervention":20},{"estimatedRecruitmentStartDate":898,"estimatedEndDate":910,"estimatedGlobalEndDate":45},"2028-01-21",[912],{"name":145,"publicStatusCode":58,"firstDecisionDate":899,"lastDecisionDate":913,"history":914},"2025-09-17T16:31:55.82",[915,916,917,918],{"source":69,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":597,"date":343,"reportingStatusCode":43,"applicationStatusCode":43},{"source":69,"applicationBusinessKey":80,"applicationType":81,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45,"assessmentOutcomeDate":45,"date":343,"reportingStatusCode":43,"applicationStatusCode":43},{"source":77,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":899,"isRMS":12},{"source":77,"applicationBusinessKey":80,"applicationType":81,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45,"eventType":78,"date":913,"isRMS":12},[920,927],{"id":921,"businessKey":70,"type":71,"status":43,"trialStatus":43,"submissionDate":922,"decisionDate":343,"decisions":923,"countryStatuses":925},"application:2024-516022-63-00:in","2024-10-14",[924],{"mscName":145,"decisionDate":899,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":12},[926],{"countryName":145,"mscName":145,"trialStatus":43,"decision":72,"decisionDate":343,"firstDecisionDate":343,"assessmentOutcome":73,"assessmentOutcomeDate":597,"reportingStatusCode":43,"applicationStatusCode":43},{"id":928,"businessKey":80,"type":81,"status":43,"trialStatus":43,"submissionDate":929,"decisionDate":929,"decisions":930,"countryStatuses":932},"application:2024-516022-63-00:nsm-1","2025-09-17",[931],{"mscName":145,"decisionDate":913,"decision":72,"assessmentOutcome":45,"eventType":78,"applicationType":81,"isRMS":12},[933],{"countryName":145,"mscName":145,"trialStatus":43,"decision":72,"decisionDate":343,"firstDecisionDate":343,"assessmentOutcome":45,"assessmentOutcomeDate":45,"reportingStatusCode":43,"applicationStatusCode":43},[935],{"id":936,"path":937,"term":427,"snippet":938},"evidence:2a8004d579050ca63430be7a","authorizedApplication.authorizedPartI.trialDetails.trialInformation.endPoint.secondaryEndPoints[1].endPoint","Identification of the best biomarkers predicting an unfavorable disease course will be carried out using conventional regression and machine learning methods. Discrimination and calibration performances will be systematically evaluated and compared for each of the models constructed.",{"retrieveUrl":940,"publicUrl":941},"https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public-api\u002Fretrieve\u002F2024-516022-63-00","https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public\u002Fview\u002F2024-516022-63-00?lang=en","d620f64326d33257ab203068b44465dbdb63ec4251b703ac4d7759872d45bc5d",{"id":944,"euct":945,"title":946,"publicTitle":946,"fullTitle":946,"shortTitle":45,"status":43,"statusCode":58,"startDateEU":459,"decisionDate":947,"publishDate":948,"trialRegion":115,"trialRegionCode":116,"medicalConditions":949,"therapeuticAreas":952,"trialCategory":954,"duration":955,"countries":958,"applications":980,"evidence":1027,"official":1032,"slug":945,"firstObservedAt":24,"lastObservedAt":6,"dateModified":8,"materialFingerprint":1035},"ctis:2023-503617-30-02","2023-503617-30-02","Boosting recovery through excitation of arousal and awareness in comatose patients: Dose finding study (BREA2KTHROUGH DOSEFINDER)","2024-05-28T07:46:20.747","2026-06-12T03:42:33.775063129",[950],{"name":951,"rareDisease":20},"Coma and other disorders of consciousness due to acute traumatic and non-traumatic brain injury",[953],{"code":247,"name":501},{"phaseCode":49,"categoryCode":44,"lowIntervention":20},{"estimatedRecruitmentStartDate":956,"estimatedEndDate":957,"estimatedGlobalEndDate":45},"2024-01-01","2028-12-31",[959],{"name":129,"publicStatusCode":58,"firstDecisionDate":947,"lastDecisionDate":960,"history":961},"2025-02-27T13:52:35.656",[962,964,966,969,970,972,974,976,977],{"source":69,"applicationBusinessKey":963,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":397,"date":763,"reportingStatusCode":43,"applicationStatusCode":43},"IN-2",{"source":69,"applicationBusinessKey":515,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":965,"date":763,"reportingStatusCode":43,"applicationStatusCode":43},"2025-02-21",{"source":69,"applicationBusinessKey":599,"applicationType":385,"status":967,"trialStatus":43,"decision":72,"assessmentOutcome":586,"assessmentOutcomeDate":968,"date":763,"reportingStatusCode":43,"applicationStatusCode":967},"Not authorised","2025-06-03",{"source":77,"applicationBusinessKey":963,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":947,"isRMS":12},{"source":77,"applicationBusinessKey":384,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45,"eventType":78,"date":971,"isRMS":12},"2024-07-31T14:09:57.948",{"source":77,"applicationBusinessKey":80,"applicationType":81,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45,"eventType":78,"date":973,"isRMS":12},"2024-12-04T14:34:23.234",{"source":77,"applicationBusinessKey":388,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45,"eventType":78,"date":975,"isRMS":12},"2024-12-18T12:08:29.966",{"source":77,"applicationBusinessKey":515,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":960,"isRMS":12},{"source":77,"applicationBusinessKey":978,"applicationType":81,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45,"eventType":78,"date":979,"isRMS":12},"NSM-4","2026-06-11T09:10:45.432",[981,988,995,1001,1007,1015,1021],{"id":982,"businessKey":963,"type":71,"status":43,"trialStatus":43,"submissionDate":983,"decisionDate":763,"decisions":984,"countryStatuses":986},"application:2023-503617-30-02:in-2","2023-12-05",[985],{"mscName":129,"decisionDate":947,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":12},[987],{"countryName":129,"mscName":129,"trialStatus":43,"decision":72,"decisionDate":763,"firstDecisionDate":763,"assessmentOutcome":73,"assessmentOutcomeDate":397,"reportingStatusCode":43,"applicationStatusCode":43},{"id":989,"businessKey":384,"type":385,"status":43,"trialStatus":43,"submissionDate":990,"decisionDate":991,"decisions":992,"countryStatuses":994},"application:2023-503617-30-02:sm-1","2024-07-12","2024-07-31",[993],{"mscName":129,"decisionDate":971,"decision":72,"assessmentOutcome":45,"eventType":78,"applicationType":385,"isRMS":12},[],{"id":996,"businessKey":80,"type":81,"status":43,"trialStatus":43,"submissionDate":997,"decisionDate":997,"decisions":998,"countryStatuses":1000},"application:2023-503617-30-02:nsm-1","2024-12-04",[999],{"mscName":129,"decisionDate":973,"decision":72,"assessmentOutcome":45,"eventType":78,"applicationType":81,"isRMS":12},[],{"id":1002,"businessKey":388,"type":385,"status":43,"trialStatus":43,"submissionDate":337,"decisionDate":1003,"decisions":1004,"countryStatuses":1006},"application:2023-503617-30-02:sm-2","2024-12-18",[1005],{"mscName":129,"decisionDate":975,"decision":72,"assessmentOutcome":45,"eventType":78,"applicationType":385,"isRMS":12},[],{"id":1008,"businessKey":515,"type":385,"status":43,"trialStatus":43,"submissionDate":1009,"decisionDate":1010,"decisions":1011,"countryStatuses":1013},"application:2023-503617-30-02:sm-4","2025-01-23","2025-02-27",[1012],{"mscName":129,"decisionDate":960,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[1014],{"countryName":129,"mscName":129,"trialStatus":43,"decision":72,"decisionDate":763,"firstDecisionDate":763,"assessmentOutcome":73,"assessmentOutcomeDate":965,"reportingStatusCode":43,"applicationStatusCode":43},{"id":1016,"businessKey":599,"type":385,"status":967,"trialStatus":43,"submissionDate":1017,"decisionDate":45,"decisions":1018,"countryStatuses":1019},"application:2023-503617-30-02:sm-5","2025-04-12",[],[1020],{"countryName":129,"mscName":129,"trialStatus":43,"decision":72,"decisionDate":763,"firstDecisionDate":763,"assessmentOutcome":586,"assessmentOutcomeDate":968,"reportingStatusCode":43,"applicationStatusCode":967},{"id":1022,"businessKey":978,"type":81,"status":43,"trialStatus":43,"submissionDate":1023,"decisionDate":1023,"decisions":1024,"countryStatuses":1026},"application:2023-503617-30-02:nsm-4","2026-06-11",[1025],{"mscName":129,"decisionDate":979,"decision":72,"assessmentOutcome":45,"eventType":78,"applicationType":81,"isRMS":12},[],[1028],{"id":1029,"path":1030,"term":427,"snippet":1031},"evidence:9958e215c38cbd891541df6c","authorizedApplication.authorizedPartI.trialDetails.trialInformation.endPoint.secondaryEndPoints[5].endPoint","Neurovascular coupling (NIRS-EEG) measures combined with EEG features from our machine learning algorithm following administration of psylocibin and apomorphine, and cortical activation during tongue mental imagery paradigm (exploratory endpoint)",{"retrieveUrl":1033,"publicUrl":1034},"https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public-api\u002Fretrieve\u002F2023-503617-30-02","https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public\u002Fview\u002F2023-503617-30-02?lang=en","d8b441b7427368479b0be8dda0b5abc2d341cf53d41a5cc31cbfa25e6b4ff984",{"id":1037,"euct":1038,"title":1039,"publicTitle":1039,"fullTitle":1039,"shortTitle":1040,"status":43,"statusCode":58,"startDateEU":922,"decisionDate":1041,"publishDate":1042,"trialRegion":115,"trialRegionCode":116,"medicalConditions":1043,"therapeuticAreas":1045,"trialCategory":1051,"duration":1052,"countries":1055,"applications":1061,"evidence":1069,"official":1074,"slug":1038,"firstObservedAt":24,"lastObservedAt":6,"dateModified":8,"materialFingerprint":1077},"ctis:2022-501892-14-00","2022-501892-14-00","Evaluation of PSMA-PET and mpMRI in high-risk prostate cancer – using histopathologic validation","PAMP2","2024-03-25T15:53:37.535","2025-02-15T02:09:15.618338441",[1044],{"name":444,"rareDisease":20},[1046,1047,1048],{"code":241,"name":242},{"code":58,"name":59},{"code":1049,"name":1050},"12","Diseases [C] - Male Urogenital Diseases [C12]",{"phaseCode":123,"categoryCode":44,"lowIntervention":20},{"estimatedRecruitmentStartDate":1053,"estimatedEndDate":1054,"estimatedGlobalEndDate":45},"2024-02-01","2031-12-31",[1056],{"name":177,"publicStatusCode":58,"firstDecisionDate":1041,"lastDecisionDate":1041,"history":1057},[1058,1060],{"source":69,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":1059,"date":1059,"reportingStatusCode":43,"applicationStatusCode":43},"2024-03-25",{"source":77,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":1041,"isRMS":12},[1062],{"id":1063,"businessKey":70,"type":71,"status":43,"trialStatus":43,"submissionDate":1064,"decisionDate":1059,"decisions":1065,"countryStatuses":1067},"application:2022-501892-14-00:in","2023-12-20",[1066],{"mscName":177,"decisionDate":1041,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":12},[1068],{"countryName":177,"mscName":177,"trialStatus":43,"decision":72,"decisionDate":1059,"firstDecisionDate":1059,"assessmentOutcome":73,"assessmentOutcomeDate":1059,"reportingStatusCode":43,"applicationStatusCode":43},[1070],{"id":1071,"path":1072,"term":427,"snippet":1073},"evidence:9bcad53da2ef099b40aecdb5","authorizedApplication.authorizedPartI.trialDetails.trialInformation.trialObjective.secondaryObjectives[3].secondaryObjective","The exploratory objective is to investigate the potential use of machine learning to predict tumour lesions properties from mpMRI and PSMA-PET",{"retrieveUrl":1075,"publicUrl":1076},"https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public-api\u002Fretrieve\u002F2022-501892-14-00","https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public\u002Fview\u002F2022-501892-14-00?lang=en","8912e1d934e859041c49621a00b7adcabf20d871a8e45e5485912510da5b8153",{"id":1079,"euct":1080,"title":1081,"publicTitle":1081,"fullTitle":1081,"shortTitle":1082,"status":43,"statusCode":58,"startDateEU":1083,"decisionDate":1084,"publishDate":1085,"trialRegion":115,"trialRegionCode":116,"medicalConditions":1086,"therapeuticAreas":1089,"trialCategory":1093,"duration":1094,"countries":1096,"applications":1121,"evidence":1165,"official":1169,"slug":1080,"firstObservedAt":24,"lastObservedAt":6,"dateModified":8,"materialFingerprint":1172},"ctis:2023-508316-27-00","2023-508316-27-00","Preoperative Indocyanine Green administration increases intraoperative detection of Liver Tumors in Imaging-guided surgery. A phase IV clinical trial.","LIVERGREEN","2024-06-10","2024-02-12T14:23:20.088","2026-07-17T03:38:53.44563369",[1087],{"name":1088,"rareDisease":20},"Patients with liver tumors that will undergo minimally invasive liver surgery",[1090],{"code":1091,"name":1092},"27","Analytical,Diagnostic,Therapeutic Techniques and Equipment [E]-Surgical Procedures, Operative [E04]",{"phaseCode":55,"categoryCode":49,"lowIntervention":12},{"estimatedRecruitmentStartDate":1053,"estimatedEndDate":1095,"estimatedGlobalEndDate":45},"2027-02-01",[1097],{"name":66,"publicStatusCode":58,"firstDecisionDate":1084,"lastDecisionDate":1098,"history":1099},"2026-07-16T13:48:49.435",[1100,1103,1105,1107,1109,1111,1112,1114,1116,1118,1120],{"source":69,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":1101,"date":1102,"reportingStatusCode":43,"applicationStatusCode":43},"2024-01-22","2024-02-12",{"source":69,"applicationBusinessKey":384,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":1104,"date":1102,"reportingStatusCode":43,"applicationStatusCode":43},"2024-04-19",{"source":69,"applicationBusinessKey":388,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":1106,"date":1102,"reportingStatusCode":43,"applicationStatusCode":43},"2025-05-27",{"source":69,"applicationBusinessKey":515,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":1108,"date":1102,"reportingStatusCode":43,"applicationStatusCode":43},"2025-08-29",{"source":69,"applicationBusinessKey":599,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":1110,"date":1102,"reportingStatusCode":43,"applicationStatusCode":43},"2026-07-16",{"source":77,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":1084,"isRMS":12},{"source":77,"applicationBusinessKey":384,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":1113,"isRMS":12},"2024-05-03T14:10:10.684",{"source":77,"applicationBusinessKey":388,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":1115,"isRMS":12},"2025-05-29T12:22:31.259",{"source":77,"applicationBusinessKey":594,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45,"eventType":78,"date":1117,"isRMS":12},"2025-05-30T11:30:58.307",{"source":77,"applicationBusinessKey":515,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":1119,"isRMS":12},"2025-08-29T11:29:51.907",{"source":77,"applicationBusinessKey":599,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":1098,"isRMS":12},[1122,1129,1137,1145,1151,1158],{"id":1123,"businessKey":70,"type":71,"status":43,"trialStatus":43,"submissionDate":1124,"decisionDate":1102,"decisions":1125,"countryStatuses":1127},"application:2023-508316-27-00:in","2023-11-28",[1126],{"mscName":66,"decisionDate":1084,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":12},[1128],{"countryName":66,"mscName":66,"trialStatus":43,"decision":72,"decisionDate":1102,"firstDecisionDate":1102,"assessmentOutcome":73,"assessmentOutcomeDate":1101,"reportingStatusCode":43,"applicationStatusCode":43},{"id":1130,"businessKey":384,"type":385,"status":43,"trialStatus":43,"submissionDate":1131,"decisionDate":1132,"decisions":1133,"countryStatuses":1135},"application:2023-508316-27-00:sm-1","2024-03-06","2024-05-03",[1134],{"mscName":66,"decisionDate":1113,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[1136],{"countryName":66,"mscName":66,"trialStatus":43,"decision":72,"decisionDate":1102,"firstDecisionDate":1102,"assessmentOutcome":73,"assessmentOutcomeDate":1104,"reportingStatusCode":43,"applicationStatusCode":43},{"id":1138,"businessKey":388,"type":385,"status":43,"trialStatus":43,"submissionDate":1139,"decisionDate":1140,"decisions":1141,"countryStatuses":1143},"application:2023-508316-27-00:sm-2","2025-03-27","2025-05-29",[1142],{"mscName":66,"decisionDate":1115,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[1144],{"countryName":66,"mscName":66,"trialStatus":43,"decision":72,"decisionDate":1102,"firstDecisionDate":1102,"assessmentOutcome":73,"assessmentOutcomeDate":1106,"reportingStatusCode":43,"applicationStatusCode":43},{"id":1146,"businessKey":594,"type":385,"status":43,"trialStatus":43,"submissionDate":1140,"decisionDate":1147,"decisions":1148,"countryStatuses":1150},"application:2023-508316-27-00:sm-3","2025-05-30",[1149],{"mscName":66,"decisionDate":1117,"decision":72,"assessmentOutcome":45,"eventType":78,"applicationType":385,"isRMS":12},[],{"id":1152,"businessKey":515,"type":385,"status":43,"trialStatus":43,"submissionDate":1153,"decisionDate":1108,"decisions":1154,"countryStatuses":1156},"application:2023-508316-27-00:sm-4","2025-08-25",[1155],{"mscName":66,"decisionDate":1119,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[1157],{"countryName":66,"mscName":66,"trialStatus":43,"decision":72,"decisionDate":1102,"firstDecisionDate":1102,"assessmentOutcome":73,"assessmentOutcomeDate":1108,"reportingStatusCode":43,"applicationStatusCode":43},{"id":1159,"businessKey":599,"type":385,"status":43,"trialStatus":43,"submissionDate":1160,"decisionDate":1110,"decisions":1161,"countryStatuses":1163},"application:2023-508316-27-00:sm-5","2026-06-09",[1162],{"mscName":66,"decisionDate":1098,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[1164],{"countryName":66,"mscName":66,"trialStatus":43,"decision":72,"decisionDate":1102,"firstDecisionDate":1102,"assessmentOutcome":73,"assessmentOutcomeDate":1110,"reportingStatusCode":43,"applicationStatusCode":43},[1166],{"id":1167,"path":482,"term":427,"snippet":1168},"evidence:b96d74d976f706cc33f26a89","…o analyze the detection of liver tumors using indocyanine green fluorescence uptake in combination with intraoperative ultrasonography and preoperative imaging test • To develop a machine-learning algorithm to detect liver tumors with indocyanine green by photographic analysis.",{"retrieveUrl":1170,"publicUrl":1171},"https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public-api\u002Fretrieve\u002F2023-508316-27-00","https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public\u002Fview\u002F2023-508316-27-00?lang=en","c5bb0a22089360eafa8a2396e0bbf12fb698bb84330d5c4ba5a975250919da22",{"id":1174,"euct":1175,"title":1176,"publicTitle":1176,"fullTitle":1176,"shortTitle":1177,"status":43,"statusCode":44,"startDateEU":45,"decisionDate":1178,"publishDate":1179,"trialRegion":115,"trialRegionCode":116,"medicalConditions":1180,"therapeuticAreas":1183,"trialCategory":1185,"duration":1186,"countries":1189,"applications":1196,"evidence":1204,"official":1210,"slug":1175,"firstObservedAt":24,"lastObservedAt":6,"dateModified":8,"materialFingerprint":1213},"ctis:2025-525008-12-00","2025-525008-12-00","An open-label multiple dose safety, tolerability and exploratory efficacy clinical trial of PST-611 in patients with geographic atrophy secondary to age-related macular degeneration","PST-611-CT2","2026-06-25T12:59:00.891","2026-06-26T03:39:08.668966418",[1181],{"name":1182,"rareDisease":20},"Geographic atrophy secondary to age-related macular degeneration",[1184],{"code":326,"name":327},{"phaseCode":58,"categoryCode":44,"lowIntervention":20},{"estimatedRecruitmentStartDate":1187,"estimatedEndDate":1188,"estimatedGlobalEndDate":45},"2026-09-01","2028-06-30",[1190],{"name":145,"publicStatusCode":44,"firstDecisionDate":1178,"lastDecisionDate":1178,"history":1191},[1192,1195],{"source":69,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"assessmentOutcomeDate":1193,"date":1194,"reportingStatusCode":43,"applicationStatusCode":43},"2026-06-22","2026-06-25",{"source":77,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73,"eventType":78,"date":1178,"isRMS":12},[1197],{"id":1198,"businessKey":70,"type":71,"status":43,"trialStatus":43,"submissionDate":1199,"decisionDate":1194,"decisions":1200,"countryStatuses":1202},"application:2025-525008-12-00:in","2026-03-19",[1201],{"mscName":145,"decisionDate":1178,"decision":134,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":12},[1203],{"countryName":145,"mscName":145,"trialStatus":43,"decision":134,"decisionDate":1194,"firstDecisionDate":1194,"assessmentOutcome":73,"assessmentOutcomeDate":1193,"reportingStatusCode":43,"applicationStatusCode":43},[1205],{"id":1206,"path":1207,"term":1208,"snippet":1209},"evidence:3c4a4c1b47c2fe0ca6df2186","authorizedApplication.authorizedPartI.trialDetails.trialInformation.endPoint.secondaryEndPoints[2].endPoint","deep learning","CFB in quantitative Contrast Sensitivity Function (qCSF) at normal luminance (Manifold Platform®) CFB in the area of retinal pigment epithelium (RPE) loss identified by deep learning-based analysis of SD-OCT CFB in the area of photoreceptor (PR) degeneration (also known as EZ layer loss) identified by deep learning-based analysis of SD-OCT",{"retrieveUrl":1211,"publicUrl":1212},"https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public-api\u002Fretrieve\u002F2025-525008-12-00","https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public\u002Fview\u002F2025-525008-12-00?lang=en","8be4c96e1e007ca74f5f71868bf5dfef55ab1864e20a226f3b2b428139133b1f",{"id":1215,"euct":1216,"title":1217,"publicTitle":1217,"fullTitle":1217,"shortTitle":1218,"status":43,"statusCode":58,"startDateEU":1219,"decisionDate":1220,"publishDate":1221,"trialRegion":115,"trialRegionCode":116,"medicalConditions":1222,"therapeuticAreas":1225,"trialCategory":1227,"duration":1228,"countries":1231,"applications":1242,"evidence":1258,"official":1263,"slug":1216,"firstObservedAt":24,"lastObservedAt":6,"dateModified":8,"materialFingerprint":1266},"ctis:2024-513248-27-00","2024-513248-27-00","Multicentre, randomized, controlled, open-label, multi-centre medicoeconomic study evaluating the efficacy of adding zoledronic acid or denosumab to Stereotaxic radiotherapy in the treatment of vertebral metastases (ZOSTER)","ZOSTER ICO-N-2018-14","2020-07-20","2024-06-17T17:55:31.466","2025-08-23T03:35:22.494162262",[1223],{"name":1224,"rareDisease":20},"Patients, men or women over 18 old, with inoperable vertebral bone metastases who must beneficit treatment with stereotactic radiotherapy",[1226],{"code":58,"name":59},{"phaseCode":123,"categoryCode":44,"lowIntervention":20},{"estimatedRecruitmentStartDate":1229,"estimatedEndDate":1230,"estimatedGlobalEndDate":45},"2020-06-23","2027-06-23",[1232],{"name":145,"publicStatusCode":58,"firstDecisionDate":1220,"lastDecisionDate":1233,"history":1234},"2025-08-22T13:17:04.856",[1235,1238,1240,1241],{"source":69,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":1236,"date":1237,"reportingStatusCode":43,"applicationStatusCode":43},"2024-06-11","2024-06-17",{"source":69,"applicationBusinessKey":384,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":1239,"date":1237,"reportingStatusCode":43,"applicationStatusCode":43},"2025-07-04",{"source":77,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":1220,"isRMS":12},{"source":77,"applicationBusinessKey":384,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":1233,"isRMS":12},[1243,1250],{"id":1244,"businessKey":70,"type":71,"status":43,"trialStatus":43,"submissionDate":1245,"decisionDate":1237,"decisions":1246,"countryStatuses":1248},"application:2024-513248-27-00:in","2024-04-22",[1247],{"mscName":145,"decisionDate":1220,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":12},[1249],{"countryName":145,"mscName":145,"trialStatus":43,"decision":72,"decisionDate":1237,"firstDecisionDate":1237,"assessmentOutcome":73,"assessmentOutcomeDate":1236,"reportingStatusCode":43,"applicationStatusCode":43},{"id":1251,"businessKey":384,"type":385,"status":43,"trialStatus":43,"submissionDate":1252,"decisionDate":1253,"decisions":1254,"countryStatuses":1256},"application:2024-513248-27-00:sm-1","2025-05-16","2025-08-22",[1255],{"mscName":145,"decisionDate":1233,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[1257],{"countryName":145,"mscName":145,"trialStatus":43,"decision":72,"decisionDate":1237,"firstDecisionDate":1237,"assessmentOutcome":73,"assessmentOutcomeDate":1239,"reportingStatusCode":43,"applicationStatusCode":43},[1259],{"id":1260,"path":1261,"term":1208,"snippet":1262},"evidence:ae6a1197ae82747da71665ae","authorizedApplication.authorizedPartI.trialDetails.trialInformation.trialObjective.secondaryObjectives[10].secondaryObjective","Determination by deep learning of a predictive model for the occurrence of a bone fracture at 1 year based on imaging examinations.",{"retrieveUrl":1264,"publicUrl":1265},"https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public-api\u002Fretrieve\u002F2024-513248-27-00","https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public\u002Fview\u002F2024-513248-27-00?lang=en","0f5350ca83eeec359c8f15ae287873fe5656aa6c506db3d95ca55c185573e333",{"id":1268,"euct":1269,"title":1270,"publicTitle":1270,"fullTitle":1270,"shortTitle":45,"status":43,"statusCode":58,"startDateEU":1271,"decisionDate":1272,"publishDate":1273,"trialRegion":115,"trialRegionCode":116,"medicalConditions":1274,"therapeuticAreas":1277,"trialCategory":1279,"duration":1280,"countries":1283,"applications":1299,"evidence":1326,"official":1331,"slug":1269,"firstObservedAt":24,"lastObservedAt":6,"dateModified":8,"materialFingerprint":1334},"ctis:2023-510304-53-00","2023-510304-53-00","INFLANET - A French Network for PET imaging of neuroinflammation in MS","2025-12-16","2024-05-30T11:29:48.045","2026-06-02T03:32:50.460963105",[1275],{"name":1276,"rareDisease":20},"Multiple sclerosis",[1278],{"code":247,"name":501},{"phaseCode":247,"categoryCode":49,"lowIntervention":20},{"estimatedRecruitmentStartDate":1281,"estimatedEndDate":1282,"estimatedGlobalEndDate":45},"2025-09-01","2027-11-01",[1284],{"name":145,"publicStatusCode":58,"firstDecisionDate":1272,"lastDecisionDate":1285,"history":1286},"2026-06-01T15:43:36.508",[1287,1289,1291,1293,1294,1296,1298],{"source":69,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":397,"date":1288,"reportingStatusCode":43,"applicationStatusCode":43},"2024-05-30",{"source":69,"applicationBusinessKey":1290,"applicationType":81,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45,"assessmentOutcomeDate":45,"date":1288,"reportingStatusCode":43,"applicationStatusCode":43},"NSM-2",{"source":69,"applicationBusinessKey":384,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":1292,"date":1288,"reportingStatusCode":43,"applicationStatusCode":43},"2025-11-07",{"source":77,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":1272,"isRMS":12},{"source":77,"applicationBusinessKey":384,"applicationType":385,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73,"eventType":78,"date":1295,"isRMS":12},"2025-11-10T15:05:05.656",{"source":77,"applicationBusinessKey":80,"applicationType":81,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45,"eventType":78,"date":1297,"isRMS":12},"2025-11-17T16:03:30.46",{"source":77,"applicationBusinessKey":1290,"applicationType":81,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45,"eventType":78,"date":1285,"isRMS":12},[1300,1306,1314,1320],{"id":1301,"businessKey":70,"type":71,"status":43,"trialStatus":43,"submissionDate":449,"decisionDate":1288,"decisions":1302,"countryStatuses":1304},"application:2023-510304-53-00:in",[1303],{"mscName":145,"decisionDate":1272,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":12},[1305],{"countryName":145,"mscName":145,"trialStatus":43,"decision":72,"decisionDate":1288,"firstDecisionDate":1288,"assessmentOutcome":73,"assessmentOutcomeDate":397,"reportingStatusCode":43,"applicationStatusCode":43},{"id":1307,"businessKey":384,"type":385,"status":43,"trialStatus":43,"submissionDate":1308,"decisionDate":1309,"decisions":1310,"countryStatuses":1312},"application:2023-510304-53-00:sm-1","2025-08-18","2025-11-10",[1311],{"mscName":145,"decisionDate":1295,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[1313],{"countryName":145,"mscName":145,"trialStatus":43,"decision":72,"decisionDate":1288,"firstDecisionDate":1288,"assessmentOutcome":73,"assessmentOutcomeDate":1292,"reportingStatusCode":43,"applicationStatusCode":43},{"id":1315,"businessKey":80,"type":81,"status":43,"trialStatus":43,"submissionDate":1316,"decisionDate":1316,"decisions":1317,"countryStatuses":1319},"application:2023-510304-53-00:nsm-1","2025-11-17",[1318],{"mscName":145,"decisionDate":1297,"decision":72,"assessmentOutcome":45,"eventType":78,"applicationType":81,"isRMS":12},[],{"id":1321,"businessKey":1290,"type":81,"status":43,"trialStatus":43,"submissionDate":62,"decisionDate":62,"decisions":1322,"countryStatuses":1324},"application:2023-510304-53-00:nsm-2",[1323],{"mscName":145,"decisionDate":1285,"decision":72,"assessmentOutcome":45,"eventType":78,"applicationType":81,"isRMS":12},[1325],{"countryName":145,"mscName":145,"trialStatus":43,"decision":72,"decisionDate":1288,"firstDecisionDate":1288,"assessmentOutcome":45,"assessmentOutcomeDate":45,"reportingStatusCode":43,"applicationStatusCode":43},[1327],{"id":1328,"path":1329,"term":1208,"snippet":1330},"evidence:ab883267ec2607de8c43720b","authorizedApplication.authorizedPartI.trialDetails.trialInformation.trialObjective.secondaryObjectives[0].secondaryObjective","…T2, FLAIR, SWI, QSM, MTR, ihMT, diffusion) and [18F]-DPA-714 DVR in each region of interest. This will include the assessment of novel algorithms that have been generated through deep learning and attempt to reproduce PET using multimodal MRI datasets.",{"retrieveUrl":1332,"publicUrl":1333},"https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public-api\u002Fretrieve\u002F2023-510304-53-00","https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public\u002Fview\u002F2023-510304-53-00?lang=en","5e6758a1f323eb78e032bb281b5bb1578ead896d23577f30102983d695d0cab2",{"id":1336,"euct":1337,"title":1338,"publicTitle":1338,"fullTitle":1338,"shortTitle":45,"status":566,"statusCode":567,"startDateEU":1339,"decisionDate":1340,"publishDate":1341,"trialRegion":115,"trialRegionCode":116,"medicalConditions":1342,"therapeuticAreas":1345,"trialCategory":1347,"duration":1348,"countries":1351,"applications":1364,"evidence":1386,"official":1394,"slug":1337,"firstObservedAt":24,"lastObservedAt":6,"dateModified":8,"materialFingerprint":1397},"ctis:2024-513123-17-00","2024-513123-17-00","CO-THEIA (COMBINATION THERAPY WITH METHOTREXATE AND ADALIMUMAB FOR UVEITIS): EFFICACY, SAFETY AND COST-EFFECTIVENESS OF METHOTREXATE, ADALIMUMAB, OR THEIR COMBINATION IN NON INFECTIOUS NON ANTERIOR UVEITIS: A MULTICENTER, RANDOMIZED, PARALLEL 3 ARMS, ACTIVE-CONTROLLED, PHASE 3 OPEN LABEL WITH BLINDED OUTCOME ASSESSMENT STUDY.","2022-01-12","2024-04-15T12:46:56.409","2025-12-03T02:31:00.71228822",[1343],{"name":1344,"rareDisease":12},"Non-infection uveitis",[1346],{"code":326,"name":327},{"phaseCode":123,"categoryCode":49,"lowIntervention":12},{"estimatedRecruitmentStartDate":1349,"estimatedEndDate":1350,"estimatedGlobalEndDate":45},"2021-09-01","2025-09-30",[1352],{"name":66,"publicStatusCode":567,"firstDecisionDate":1340,"lastDecisionDate":1353,"history":1354},"2025-03-03T13:19:19.438",[1355,1357,1358,1360,1361,1363],{"source":69,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":1356,"date":1356,"reportingStatusCode":566,"applicationStatusCode":43},"2024-04-15",{"source":69,"applicationBusinessKey":384,"applicationType":385,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":653,"date":1356,"reportingStatusCode":566,"applicationStatusCode":43},{"source":69,"applicationBusinessKey":594,"applicationType":385,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73,"assessmentOutcomeDate":1359,"date":1356,"reportingStatusCode":566,"applicationStatusCode":43},"2025-02-13",{"source":77,"applicationBusinessKey":70,"applicationType":71,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73,"eventType":78,"date":1340,"isRMS":12},{"source":77,"applicationBusinessKey":384,"applicationType":385,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73,"eventType":78,"date":1362,"isRMS":12},"2024-10-24T09:38:28.218",{"source":77,"applicationBusinessKey":594,"applicationType":385,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73,"eventType":78,"date":1353,"isRMS":12},[1365,1372,1379],{"id":1366,"businessKey":70,"type":71,"status":43,"trialStatus":566,"submissionDate":1367,"decisionDate":1356,"decisions":1368,"countryStatuses":1370},"application:2024-513123-17-00:in","2024-04-09",[1369],{"mscName":66,"decisionDate":1340,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":71,"isRMS":12},[1371],{"countryName":66,"mscName":66,"trialStatus":566,"decision":72,"decisionDate":1356,"firstDecisionDate":1356,"assessmentOutcome":73,"assessmentOutcomeDate":1356,"reportingStatusCode":566,"applicationStatusCode":43},{"id":1373,"businessKey":384,"type":385,"status":43,"trialStatus":566,"submissionDate":1374,"decisionDate":653,"decisions":1375,"countryStatuses":1377},"application:2024-513123-17-00:sm-1","2024-10-17",[1376],{"mscName":66,"decisionDate":1362,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[1378],{"countryName":66,"mscName":66,"trialStatus":566,"decision":72,"decisionDate":1356,"firstDecisionDate":1356,"assessmentOutcome":73,"assessmentOutcomeDate":653,"reportingStatusCode":566,"applicationStatusCode":43},{"id":1380,"businessKey":594,"type":385,"status":43,"trialStatus":566,"submissionDate":1381,"decisionDate":386,"decisions":1382,"countryStatuses":1384},"application:2024-513123-17-00:sm-3","2024-12-19",[1383],{"mscName":66,"decisionDate":1353,"decision":72,"assessmentOutcome":73,"eventType":78,"applicationType":385,"isRMS":12},[1385],{"countryName":66,"mscName":66,"trialStatus":566,"decision":72,"decisionDate":1356,"firstDecisionDate":1356,"assessmentOutcome":73,"assessmentOutcomeDate":1359,"reportingStatusCode":566,"applicationStatusCode":43},[1387,1391],{"id":1388,"path":1389,"term":1208,"snippet":1390},"evidence:67ea123bff83551f676f7fa0","authorizedApplication.authorizedPartI.trialDetails.trialInformation.trialObjective.secondaryObjectives[8].secondaryObjective","To generate deep learning models based on convolutional neural networks to automatically quantify image biomarkers related to clinical manifestations, diagnosis and pharmacological response.",{"id":1392,"path":1389,"term":1393,"snippet":1390},"evidence:3cc370ad69b3b933b89a0c07","neural network",{"retrieveUrl":1395,"publicUrl":1396},"https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public-api\u002Fretrieve\u002F2024-513123-17-00","https:\u002F\u002Feuclinicaltrials.eu\u002Fctis-public\u002Fview\u002F2024-513123-17-00?lang=en","b71b9a85591f14772a82c828683263176b083a2ff66d9a9f087f3dd56550f7cb",[1399,1400,1401,1402,1403,1404,1405,1406,1407,1408,1409,1410,1411,1412,1413,1414,1415,1416,1417,1418,1419,1420,1421,1422,1423,1424,1425],{"id":99,"path":100,"term":101,"snippet":102,"studyId":38,"euct":39,"sourceUrl":105},{"id":207,"path":208,"term":101,"snippet":209,"studyId":108,"euct":109,"sourceUrl":212},{"id":268,"path":269,"term":101,"snippet":270,"studyId":215,"euct":216,"sourceUrl":273},{"id":306,"path":307,"term":101,"snippet":308,"studyId":276,"euct":277,"sourceUrl":311},{"id":350,"path":351,"term":101,"snippet":316,"studyId":314,"euct":315,"sourceUrl":354},{"id":420,"path":421,"term":101,"snippet":360,"studyId":357,"euct":358,"sourceUrl":431},{"id":423,"path":351,"term":101,"snippet":359,"studyId":357,"euct":358,"sourceUrl":431},{"id":425,"path":426,"term":427,"snippet":428,"studyId":357,"euct":358,"sourceUrl":431},{"id":479,"path":351,"term":101,"snippet":436,"studyId":434,"euct":435,"sourceUrl":486},{"id":481,"path":482,"term":101,"snippet":483,"studyId":434,"euct":435,"sourceUrl":486},{"id":553,"path":554,"term":101,"snippet":555,"studyId":489,"euct":490,"sourceUrl":558},{"id":682,"path":421,"term":427,"snippet":564,"studyId":561,"euct":562,"sourceUrl":691},{"id":684,"path":351,"term":101,"snippet":685,"studyId":561,"euct":562,"sourceUrl":691},{"id":687,"path":482,"term":427,"snippet":688,"studyId":561,"euct":562,"sourceUrl":691},{"id":793,"path":794,"term":101,"snippet":795,"studyId":694,"euct":695,"sourceUrl":801},{"id":797,"path":794,"term":427,"snippet":798,"studyId":694,"euct":695,"sourceUrl":801},{"id":845,"path":307,"term":427,"snippet":846,"studyId":804,"euct":805,"sourceUrl":849},{"id":885,"path":886,"term":427,"snippet":887,"studyId":852,"euct":853,"sourceUrl":890},{"id":936,"path":937,"term":427,"snippet":938,"studyId":893,"euct":894,"sourceUrl":941},{"id":1029,"path":1030,"term":427,"snippet":1031,"studyId":944,"euct":945,"sourceUrl":1034},{"id":1071,"path":1072,"term":427,"snippet":1073,"studyId":1037,"euct":1038,"sourceUrl":1076},{"id":1167,"path":482,"term":427,"snippet":1168,"studyId":1079,"euct":1080,"sourceUrl":1171},{"id":1206,"path":1207,"term":1208,"snippet":1209,"studyId":1174,"euct":1175,"sourceUrl":1212},{"id":1260,"path":1261,"term":1208,"snippet":1262,"studyId":1215,"euct":1216,"sourceUrl":1265},{"id":1328,"path":1329,"term":1208,"snippet":1330,"studyId":1268,"euct":1269,"sourceUrl":1333},{"id":1388,"path":1389,"term":1208,"snippet":1390,"studyId":1336,"euct":1337,"sourceUrl":1396},{"id":1392,"path":1389,"term":1393,"snippet":1390,"studyId":1336,"euct":1337,"sourceUrl":1396},[1427,1431,1434,1437,1440,1442,1444,1446,1448,1450,1452,1454,1456,1458,1460,1462,1464,1466,1468,1470,1472,1474,1476,1478,1480,1482,1484,1486,1488,1490,1492,1494,1496,1498,1500,1502,1504,1506,1508,1510,1512,1514,1516,1518,1520,1522,1524,1526,1528,1530,1532,1534,1536,1538,1540,1542,1544,1546,1548,1550,1552,1554,1556,1558,1560,1562,1564,1566,1568,1570,1572,1574,1576,1578,1580,1582,1584,1586,1588,1590,1592,1594,1596,1598,1600,1602,1604,1606,1608,1610,1612,1614,1616,1618,1620,1622,1624,1626,1628,1630,1632,1634,1636,1638,1640,1642,1644,1646,1648,1650,1652,1654,1656,1658,1660,1662,1664,1666,1668,1670,1672,1674,1676,1678,1680,1682,1684,1686,1688,1690,1692,1694,1696,1698,1700,1702,1704,1706,1708,1710,1712,1714,1716,1718,1720,1722,1724,1726,1728,1730,1732,1734,1736,1738,1740,1742,1744,1746,1748,1750,1752,1754,1756,1758,1760,1762,1764,1766,1768,1770,1772,1774,1776,1778,1780,1782,1784,1786,1788,1790,1792,1794,1796,1798,1800,1802,1804,1806,1808,1810,1812,1814,1816,1818,1820,1822,1824,1826,1828,1830,1832,1834,1836,1838,1840,1842,1844,1846,1848,1850,1852,1854,1856,1858,1860,1862,1864,1866,1868,1870,1872,1874,1876,1878,1880,1882,1884,1886,1888,1890,1892,1894,1896,1898,1900,1904,1906,1908,1910,1912,1914,1916,1918,1920,1922,1924,1926,1928,1930,1932,1934,1936,1938,1940],{"id":1428,"studyId":694,"euct":695,"type":1429,"date":741,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:b24126922c6f247dc6c19729","application_submitted","official_record_date",{"id":1432,"studyId":694,"euct":695,"type":1433,"date":713,"timeBasis":1430,"applicationBusinessKey":70,"country":139,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:ad951f389ca507874794f042","country_assessment",{"id":1435,"studyId":694,"euct":695,"type":1436,"date":714,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:b2803aa7c768acc0e01c6e69","application_status",{"id":1438,"studyId":694,"euct":695,"type":1439,"date":698,"timeBasis":1430,"applicationBusinessKey":70,"country":139,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:87fafecd32a593cf82035c6c","country_decision",{"id":1441,"studyId":561,"euct":562,"type":1429,"date":622,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:f8684d4d6b66e9ceb72845e6",{"id":1443,"studyId":694,"euct":695,"type":1429,"date":748,"timeBasis":1430,"applicationBusinessKey":384,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:6e1fb77f8007a32acbf7d683",{"id":1445,"studyId":561,"euct":562,"type":1433,"date":587,"timeBasis":1430,"applicationBusinessKey":70,"country":582,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":586},"event:089707fc6e533332732bdb9c",{"id":1447,"studyId":561,"euct":562,"type":1436,"date":588,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:b819d0ee2e8a4a88f6b7b3de",{"id":1449,"studyId":561,"euct":562,"type":1439,"date":569,"timeBasis":1430,"applicationBusinessKey":70,"country":582,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":586},"event:83a724d2fd63910b0df54d56",{"id":1451,"studyId":694,"euct":695,"type":1433,"date":718,"timeBasis":1430,"applicationBusinessKey":384,"country":139,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":717},"event:841501df39d679752c076bc9",{"id":1453,"studyId":561,"euct":562,"type":1429,"date":629,"timeBasis":1430,"applicationBusinessKey":384,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:6228ac0f69c8014b344e5307",{"id":1455,"studyId":694,"euct":695,"type":1436,"date":749,"timeBasis":1430,"applicationBusinessKey":384,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:78049cd6a7473adf7beacee0",{"id":1457,"studyId":694,"euct":695,"type":1439,"date":727,"timeBasis":1430,"applicationBusinessKey":384,"country":139,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":717},"event:981d322651341a9b522acd1a",{"id":1459,"studyId":561,"euct":562,"type":1433,"date":590,"timeBasis":1430,"applicationBusinessKey":384,"country":582,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73},"event:146830a6cf3d6801dd34222c",{"id":1461,"studyId":561,"euct":562,"type":1436,"date":630,"timeBasis":1430,"applicationBusinessKey":384,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:34943337c96bd3cbb18b4477",{"id":1463,"studyId":561,"euct":562,"type":1439,"date":606,"timeBasis":1430,"applicationBusinessKey":384,"country":582,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73},"event:59b3ee677c86a21d39a2effa",{"id":1465,"studyId":489,"euct":490,"type":1429,"date":525,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:840f606c6d033a766786f795",{"id":1467,"studyId":561,"euct":562,"type":1429,"date":637,"timeBasis":1430,"applicationBusinessKey":388,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:075b95741eb02bf45bb5571d",{"id":1469,"studyId":561,"euct":562,"type":1433,"date":592,"timeBasis":1430,"applicationBusinessKey":388,"country":582,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73},"event:b54786f5f5e25e6b889cca89",{"id":1471,"studyId":561,"euct":562,"type":1436,"date":638,"timeBasis":1430,"applicationBusinessKey":388,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:6a09bbc29406dc3f2eb5b5b8",{"id":1473,"studyId":561,"euct":562,"type":1439,"date":608,"timeBasis":1430,"applicationBusinessKey":388,"country":582,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73},"event:276bbb1b4f6910664a9aef47",{"id":1475,"studyId":1079,"euct":1080,"type":1429,"date":1124,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:bea5982d5b160eebab1f4361",{"id":1477,"studyId":694,"euct":695,"type":1429,"date":756,"timeBasis":1430,"applicationBusinessKey":80,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:49247209725ba9a4b1ccdbb5",{"id":1479,"studyId":694,"euct":695,"type":1436,"date":756,"timeBasis":1430,"applicationBusinessKey":80,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:e8fc4121b87e750021ad59da",{"id":1481,"studyId":694,"euct":695,"type":1439,"date":729,"timeBasis":1430,"applicationBusinessKey":80,"country":139,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45},"event:bca6c3df46885dc59ccbe44f",{"id":1483,"studyId":944,"euct":945,"type":1429,"date":983,"timeBasis":1430,"applicationBusinessKey":963,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:e9a4f9052bb5e2a7783e970c",{"id":1485,"studyId":1037,"euct":1038,"type":1429,"date":1064,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:ee5adb2d4ec8f29fadbcb33e",{"id":1487,"studyId":489,"euct":490,"type":1436,"date":511,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:73378857daf3818fd1a4ccf2",{"id":1489,"studyId":489,"euct":490,"type":1433,"date":511,"timeBasis":1430,"applicationBusinessKey":70,"country":158,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:c3ea2793798b14783f53d0b5",{"id":1491,"studyId":489,"euct":490,"type":1439,"date":494,"timeBasis":1430,"applicationBusinessKey":70,"country":158,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:02e9e4b92ecef43a99707aaa",{"id":1493,"studyId":1079,"euct":1080,"type":1433,"date":1101,"timeBasis":1430,"applicationBusinessKey":70,"country":66,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:8791e0397d61f3de7d11fb5e",{"id":1495,"studyId":1079,"euct":1080,"type":1436,"date":1102,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:bb01a8f4588aeb8943bd30d1",{"id":1497,"studyId":1079,"euct":1080,"type":1439,"date":1084,"timeBasis":1430,"applicationBusinessKey":70,"country":66,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:11de4ba5fcc91bb9e05665a3",{"id":1499,"studyId":434,"euct":435,"type":1429,"date":465,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:689af59fdd6b464e12e8523f",{"id":1501,"studyId":1268,"euct":1269,"type":1429,"date":449,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:e88d1d3f879e06e5e6830249",{"id":1503,"studyId":1079,"euct":1080,"type":1429,"date":1131,"timeBasis":1430,"applicationBusinessKey":384,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:af4583cbeff03ad4247cc48f",{"id":1505,"studyId":561,"euct":562,"type":1429,"date":645,"timeBasis":1430,"applicationBusinessKey":594,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:2b3432480ade3ab189d33425",{"id":1507,"studyId":1037,"euct":1038,"type":1433,"date":1059,"timeBasis":1430,"applicationBusinessKey":70,"country":177,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:3b25848923ba7f5c86ab1108",{"id":1509,"studyId":1037,"euct":1038,"type":1436,"date":1059,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:8ebda954d7e9e2078a982d07",{"id":1511,"studyId":1037,"euct":1038,"type":1439,"date":1041,"timeBasis":1430,"applicationBusinessKey":70,"country":177,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:bfc0edbfac61d7c8dd8dd280",{"id":1513,"studyId":1336,"euct":1337,"type":1429,"date":1367,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:bfc45ec5e8f10950df353685",{"id":1515,"studyId":1336,"euct":1337,"type":1433,"date":1356,"timeBasis":1430,"applicationBusinessKey":70,"country":66,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73},"event:173dc5b3a1c790d780fb7bfd",{"id":1517,"studyId":1336,"euct":1337,"type":1436,"date":1356,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:4fea2ae8880a821723813268",{"id":1519,"studyId":1336,"euct":1337,"type":1439,"date":1340,"timeBasis":1430,"applicationBusinessKey":70,"country":66,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73},"event:5ae594f49426d22b40564bec",{"id":1521,"studyId":1079,"euct":1080,"type":1433,"date":1104,"timeBasis":1430,"applicationBusinessKey":384,"country":66,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:f0c48b05a04c57901e8bf9e4",{"id":1523,"studyId":1215,"euct":1216,"type":1429,"date":1245,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:3b886b3a3953978acc6b3bc9",{"id":1525,"studyId":561,"euct":562,"type":1433,"date":595,"timeBasis":1430,"applicationBusinessKey":594,"country":582,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73},"event:9399492d7fbc7c20087f2ec4",{"id":1527,"studyId":561,"euct":562,"type":1436,"date":646,"timeBasis":1430,"applicationBusinessKey":594,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:9815d79bcf95dfc4c111d050",{"id":1529,"studyId":561,"euct":562,"type":1439,"date":610,"timeBasis":1430,"applicationBusinessKey":594,"country":582,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73},"event:9ccb3d708684689dff376626",{"id":1531,"studyId":1079,"euct":1080,"type":1436,"date":1132,"timeBasis":1430,"applicationBusinessKey":384,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:7ba509bb5c0ee708b72cd69d",{"id":1533,"studyId":1079,"euct":1080,"type":1439,"date":1113,"timeBasis":1430,"applicationBusinessKey":384,"country":66,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:7b49da59fdde0b799406769c",{"id":1535,"studyId":434,"euct":435,"type":1433,"date":397,"timeBasis":1430,"applicationBusinessKey":70,"country":453,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:28b6f95748b75b0a4c4de88e",{"id":1537,"studyId":944,"euct":945,"type":1433,"date":397,"timeBasis":1430,"applicationBusinessKey":963,"country":129,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:35bae4ca0988e70b63caa1b1",{"id":1539,"studyId":1268,"euct":1269,"type":1433,"date":397,"timeBasis":1430,"applicationBusinessKey":70,"country":145,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:5023c20148379befbb51106e",{"id":1541,"studyId":357,"euct":358,"type":1429,"date":397,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:567f51954e08ede679e39b3b",{"id":1543,"studyId":694,"euct":695,"type":1429,"date":763,"timeBasis":1430,"applicationBusinessKey":594,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:28c2d56bb3018073cdfe51ae",{"id":1545,"studyId":944,"euct":945,"type":1436,"date":763,"timeBasis":1430,"applicationBusinessKey":963,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:e32053170c6f7d8d9f5a16a8",{"id":1547,"studyId":944,"euct":945,"type":1439,"date":947,"timeBasis":1430,"applicationBusinessKey":963,"country":129,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:374c889625d42293df53ef5c",{"id":1549,"studyId":434,"euct":435,"type":1436,"date":457,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:87d0f29974ebe37ebd02d59c",{"id":1551,"studyId":434,"euct":435,"type":1439,"date":440,"timeBasis":1430,"applicationBusinessKey":70,"country":453,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:d48a022d98977dbd462b3c13",{"id":1553,"studyId":1268,"euct":1269,"type":1436,"date":1288,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:cac343d753876203c24602a8",{"id":1555,"studyId":1268,"euct":1269,"type":1439,"date":1272,"timeBasis":1430,"applicationBusinessKey":70,"country":145,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:0e8008269c91e9df06b92770",{"id":1557,"studyId":694,"euct":695,"type":1436,"date":764,"timeBasis":1430,"applicationBusinessKey":594,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:ccab14903a4878f2b39516ae",{"id":1559,"studyId":694,"euct":695,"type":1439,"date":731,"timeBasis":1430,"applicationBusinessKey":594,"country":139,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45},"event:b9a173c8512ed87a8f52eba7",{"id":1561,"studyId":1215,"euct":1216,"type":1433,"date":1236,"timeBasis":1430,"applicationBusinessKey":70,"country":145,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:1911458aa3dec6cd0ce2a885",{"id":1563,"studyId":1215,"euct":1216,"type":1436,"date":1237,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:0f464a63d86ff321bd33b2a8",{"id":1565,"studyId":1215,"euct":1216,"type":1439,"date":1220,"timeBasis":1430,"applicationBusinessKey":70,"country":145,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:67360d74ca47254c30a92059",{"id":1567,"studyId":489,"euct":490,"type":1429,"date":532,"timeBasis":1430,"applicationBusinessKey":384,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:4d952d2b0c5e08965f2ea023",{"id":1569,"studyId":944,"euct":945,"type":1429,"date":990,"timeBasis":1430,"applicationBusinessKey":384,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:6f92db24ea43679fe0a5867d",{"id":1571,"studyId":944,"euct":945,"type":1436,"date":991,"timeBasis":1430,"applicationBusinessKey":384,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:e35f08dc728ee9b10033147f",{"id":1573,"studyId":944,"euct":945,"type":1439,"date":971,"timeBasis":1430,"applicationBusinessKey":384,"country":129,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45},"event:0cec6937d1b634057cc3eacd",{"id":1575,"studyId":694,"euct":695,"type":1429,"date":771,"timeBasis":1430,"applicationBusinessKey":602,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:d8ac82cc8c055b45cf2101d8",{"id":1577,"studyId":357,"euct":358,"type":1433,"date":381,"timeBasis":1430,"applicationBusinessKey":70,"country":145,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:13aed04d9a63cff676113c12",{"id":1579,"studyId":489,"euct":490,"type":1436,"date":533,"timeBasis":1430,"applicationBusinessKey":384,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:d423a7121aee0855a5e6e176",{"id":1581,"studyId":489,"euct":490,"type":1439,"date":518,"timeBasis":1430,"applicationBusinessKey":384,"country":158,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45},"event:887869bd8e88eb4fd29d4e8f",{"id":1583,"studyId":357,"euct":358,"type":1436,"date":382,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:0d8da48fb7a462af53cdd465",{"id":1585,"studyId":357,"euct":358,"type":1439,"date":363,"timeBasis":1430,"applicationBusinessKey":70,"country":145,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:768e4a4b7ecc27cbe7d269b1",{"id":1587,"studyId":694,"euct":695,"type":1433,"date":721,"timeBasis":1430,"applicationBusinessKey":602,"country":139,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:1ee07964c7e16184210d0a46",{"id":1589,"studyId":694,"euct":695,"type":1436,"date":772,"timeBasis":1430,"applicationBusinessKey":602,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:e9c9a8303b8df9e1143db04d",{"id":1591,"studyId":694,"euct":695,"type":1439,"date":733,"timeBasis":1430,"applicationBusinessKey":602,"country":139,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:f05ecd2c9a64ffe47f35034e",{"id":1593,"studyId":852,"euct":853,"type":1429,"date":878,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:d38653d3daf35807b9ed15da",{"id":1595,"studyId":893,"euct":894,"type":1429,"date":922,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:f2bc6cceeafcc17519ac4d35",{"id":1597,"studyId":1336,"euct":1337,"type":1429,"date":1374,"timeBasis":1430,"applicationBusinessKey":384,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:429a909ace87f9b49a7e8c6d",{"id":1599,"studyId":1336,"euct":1337,"type":1436,"date":653,"timeBasis":1430,"applicationBusinessKey":384,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:1d243bb3cf4466b31a0e75e2",{"id":1601,"studyId":1336,"euct":1337,"type":1433,"date":653,"timeBasis":1430,"applicationBusinessKey":384,"country":66,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73},"event:ebf7ab6cddce20797e189956",{"id":1603,"studyId":561,"euct":562,"type":1429,"date":653,"timeBasis":1430,"applicationBusinessKey":515,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:f469ccdbb5240928e377f759",{"id":1605,"studyId":1336,"euct":1337,"type":1439,"date":1362,"timeBasis":1430,"applicationBusinessKey":384,"country":66,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73},"event:f7bb7c877d8f04d75f53c775",{"id":1607,"studyId":893,"euct":894,"type":1433,"date":597,"timeBasis":1430,"applicationBusinessKey":70,"country":145,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:6e8bda17db692f5f88c99524",{"id":1609,"studyId":561,"euct":562,"type":1433,"date":597,"timeBasis":1430,"applicationBusinessKey":515,"country":582,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73},"event:dd8bc8fc7c8155e10fa66009",{"id":1611,"studyId":893,"euct":894,"type":1436,"date":343,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:382b7600e04886622b70bcc8",{"id":1613,"studyId":314,"euct":315,"type":1429,"date":343,"timeBasis":1430,"applicationBusinessKey":133,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:483571681d394ab315adc190",{"id":1615,"studyId":561,"euct":562,"type":1436,"date":343,"timeBasis":1430,"applicationBusinessKey":515,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:bdf532a9f519bf4efed24bb2",{"id":1617,"studyId":561,"euct":562,"type":1439,"date":612,"timeBasis":1430,"applicationBusinessKey":515,"country":582,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73},"event:9f81f1084bec94dfc8c01fb6",{"id":1619,"studyId":893,"euct":894,"type":1439,"date":899,"timeBasis":1430,"applicationBusinessKey":70,"country":145,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:7fdf6dea09cf66f0517bde30",{"id":1621,"studyId":852,"euct":853,"type":1433,"date":872,"timeBasis":1430,"applicationBusinessKey":70,"country":164,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:7d66ef2bc66dc42a3363d176",{"id":1623,"studyId":852,"euct":853,"type":1436,"date":873,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:1921821cfc893ee0b762c440",{"id":1625,"studyId":852,"euct":853,"type":1439,"date":858,"timeBasis":1430,"applicationBusinessKey":70,"country":164,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:3002485ee73debc11a10c142",{"id":1627,"studyId":944,"euct":945,"type":1436,"date":997,"timeBasis":1430,"applicationBusinessKey":80,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:af44d71f715aceed6b7b0744",{"id":1629,"studyId":944,"euct":945,"type":1429,"date":997,"timeBasis":1430,"applicationBusinessKey":80,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:dcc819eae2dd06419d36e560",{"id":1631,"studyId":944,"euct":945,"type":1439,"date":973,"timeBasis":1430,"applicationBusinessKey":80,"country":129,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45},"event:d0d029a609dfb8697a6f70d6",{"id":1633,"studyId":314,"euct":315,"type":1433,"date":337,"timeBasis":1430,"applicationBusinessKey":133,"country":334,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:14b7ceed16dc29bb80277af0",{"id":1635,"studyId":944,"euct":945,"type":1429,"date":337,"timeBasis":1430,"applicationBusinessKey":388,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:26be88b2131a7cc1609c0e14",{"id":1637,"studyId":944,"euct":945,"type":1436,"date":1003,"timeBasis":1430,"applicationBusinessKey":388,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:ca1c67e9111eadd72235cb63",{"id":1639,"studyId":944,"euct":945,"type":1439,"date":975,"timeBasis":1430,"applicationBusinessKey":388,"country":129,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45},"event:a686bef5e101d5aa22dd4e10",{"id":1641,"studyId":1336,"euct":1337,"type":1429,"date":1381,"timeBasis":1430,"applicationBusinessKey":594,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:273f85654e67c66b59c9ed1b",{"id":1643,"studyId":804,"euct":805,"type":1429,"date":472,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:6b76b35b570ad78cecb028c9",{"id":1645,"studyId":434,"euct":435,"type":1429,"date":472,"timeBasis":1430,"applicationBusinessKey":388,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:727bfec1d8f8917c95ec9a00",{"id":1647,"studyId":314,"euct":315,"type":1436,"date":338,"timeBasis":1430,"applicationBusinessKey":133,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:3d3d65c5fc8c97cf8c2de29f",{"id":1649,"studyId":314,"euct":315,"type":1439,"date":319,"timeBasis":1430,"applicationBusinessKey":133,"country":334,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:57c86ab9e9d64643d9cffaf0",{"id":1651,"studyId":804,"euct":805,"type":1433,"date":824,"timeBasis":1430,"applicationBusinessKey":70,"country":139,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:935ab25f48ef3e5ec8fd1f22",{"id":1653,"studyId":944,"euct":945,"type":1429,"date":1009,"timeBasis":1430,"applicationBusinessKey":515,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:2b7345f79dc50aec01d00a91",{"id":1655,"studyId":804,"euct":805,"type":1436,"date":404,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:affdb1e19c940f2bd6615f1b",{"id":1657,"studyId":357,"euct":358,"type":1429,"date":404,"timeBasis":1430,"applicationBusinessKey":384,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:eda0c02a9a5ee673cbd72d1e",{"id":1659,"studyId":804,"euct":805,"type":1439,"date":808,"timeBasis":1430,"applicationBusinessKey":70,"country":139,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:24cd8519a38a69e9fb742f15",{"id":1661,"studyId":561,"euct":562,"type":1429,"date":660,"timeBasis":1430,"applicationBusinessKey":614,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:7f0dfe9789be9582df3c85ef",{"id":1663,"studyId":561,"euct":562,"type":1436,"date":660,"timeBasis":1430,"applicationBusinessKey":614,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:c781685e94e0d305ad8de498",{"id":1665,"studyId":561,"euct":562,"type":1439,"date":615,"timeBasis":1430,"applicationBusinessKey":614,"country":582,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":45},"event:d86c398bffe563d0c384a82a",{"id":1667,"studyId":489,"euct":490,"type":1429,"date":539,"timeBasis":1430,"applicationBusinessKey":388,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:1394164841404ff3d37b740f",{"id":1669,"studyId":1336,"euct":1337,"type":1433,"date":1359,"timeBasis":1430,"applicationBusinessKey":594,"country":66,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73},"event:084ac1b9d052ad16cc0b00bb",{"id":1671,"studyId":561,"euct":562,"type":1429,"date":666,"timeBasis":1430,"applicationBusinessKey":599,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:1d88541719c181a8d62df09a",{"id":1673,"studyId":944,"euct":945,"type":1433,"date":965,"timeBasis":1430,"applicationBusinessKey":515,"country":129,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:f0e954aeaf496bd905feb26e",{"id":1675,"studyId":434,"euct":435,"type":1436,"date":459,"timeBasis":1430,"applicationBusinessKey":388,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:4227828f43a53807cd71955b",{"id":1677,"studyId":434,"euct":435,"type":1433,"date":459,"timeBasis":1430,"applicationBusinessKey":388,"country":453,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:8f75c00e651eb9e95b5cc759",{"id":1679,"studyId":434,"euct":435,"type":1439,"date":454,"timeBasis":1430,"applicationBusinessKey":388,"country":453,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:2215abfd2f10534b502f32a2",{"id":1681,"studyId":944,"euct":945,"type":1436,"date":1010,"timeBasis":1430,"applicationBusinessKey":515,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:5c75ec365b9f82866a3ce1a0",{"id":1683,"studyId":944,"euct":945,"type":1439,"date":960,"timeBasis":1430,"applicationBusinessKey":515,"country":129,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:bd248cfd992fd1c2e4ba79d7",{"id":1685,"studyId":1336,"euct":1337,"type":1436,"date":386,"timeBasis":1430,"applicationBusinessKey":594,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:4312ba99f4b5dd70d457e72f",{"id":1687,"studyId":357,"euct":358,"type":1433,"date":386,"timeBasis":1430,"applicationBusinessKey":384,"country":145,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:cb5596264608b3f4c6a8e6ee",{"id":1689,"studyId":1336,"euct":1337,"type":1439,"date":1353,"timeBasis":1430,"applicationBusinessKey":594,"country":66,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73},"event:16ffe5ea6920e7c9f194af27",{"id":1691,"studyId":694,"euct":695,"type":1429,"date":779,"timeBasis":1430,"applicationBusinessKey":723,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:7cd5cb441d4462bc203680e3",{"id":1693,"studyId":561,"euct":562,"type":1433,"date":600,"timeBasis":1430,"applicationBusinessKey":599,"country":582,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73},"event:8acc43eace13ba0bd74f51bd",{"id":1695,"studyId":561,"euct":562,"type":1436,"date":667,"timeBasis":1430,"applicationBusinessKey":599,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:16269ebd9ba8b8f0098c0105",{"id":1697,"studyId":561,"euct":562,"type":1439,"date":617,"timeBasis":1430,"applicationBusinessKey":599,"country":582,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73},"event:ae3388a2129aec025f035a16",{"id":1699,"studyId":1079,"euct":1080,"type":1429,"date":1139,"timeBasis":1430,"applicationBusinessKey":388,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:f1fab3ee643c17231ae06c87",{"id":1701,"studyId":694,"euct":695,"type":1433,"date":724,"timeBasis":1430,"applicationBusinessKey":723,"country":139,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:20611dd3b30b493759b3cf8f",{"id":1703,"studyId":694,"euct":695,"type":1436,"date":780,"timeBasis":1430,"applicationBusinessKey":723,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:e0b0329111986361fbd596b8",{"id":1705,"studyId":694,"euct":695,"type":1439,"date":710,"timeBasis":1430,"applicationBusinessKey":723,"country":139,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:91db59489559fae4cfb4b32f",{"id":1707,"studyId":489,"euct":490,"type":1436,"date":513,"timeBasis":1430,"applicationBusinessKey":388,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:0fc70e36174b3a797e0475b7",{"id":1709,"studyId":489,"euct":490,"type":1433,"date":513,"timeBasis":1430,"applicationBusinessKey":388,"country":158,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:4b20d275ff529b5cfb781088",{"id":1711,"studyId":489,"euct":490,"type":1439,"date":520,"timeBasis":1430,"applicationBusinessKey":388,"country":158,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:c66431a67baa3bac43842d74",{"id":1713,"studyId":944,"euct":945,"type":1429,"date":1017,"timeBasis":1430,"applicationBusinessKey":599,"country":45,"status":967,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:48493bd5d01940bc5b0ec5dc",{"id":1715,"studyId":357,"euct":358,"type":1436,"date":405,"timeBasis":1430,"applicationBusinessKey":384,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:14fe2341e3e3ed444c77eef5",{"id":1717,"studyId":357,"euct":358,"type":1439,"date":392,"timeBasis":1430,"applicationBusinessKey":384,"country":145,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:b111ae4a28eca6fcbe5c655f",{"id":1719,"studyId":1215,"euct":1216,"type":1429,"date":1252,"timeBasis":1430,"applicationBusinessKey":384,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:d18de1b88a89c71a6b464d6d",{"id":1721,"studyId":1079,"euct":1080,"type":1433,"date":1106,"timeBasis":1430,"applicationBusinessKey":388,"country":66,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:7349eb62819139d358c9e4bc",{"id":1723,"studyId":1079,"euct":1080,"type":1436,"date":1140,"timeBasis":1430,"applicationBusinessKey":388,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:56dbb898efa851f77303c048",{"id":1725,"studyId":1079,"euct":1080,"type":1429,"date":1140,"timeBasis":1430,"applicationBusinessKey":594,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:bf86e9582dc2240ce7a6ea7d",{"id":1727,"studyId":1079,"euct":1080,"type":1439,"date":1115,"timeBasis":1430,"applicationBusinessKey":388,"country":66,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:c6f4b0756ff6bf776d1380a5",{"id":1729,"studyId":1079,"euct":1080,"type":1436,"date":1147,"timeBasis":1430,"applicationBusinessKey":594,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:a6ac322aa5a8762f99bbf576",{"id":1731,"studyId":1079,"euct":1080,"type":1439,"date":1117,"timeBasis":1430,"applicationBusinessKey":594,"country":66,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45},"event:664da77763347cf765c577ed",{"id":1733,"studyId":944,"euct":945,"type":1433,"date":968,"timeBasis":1430,"applicationBusinessKey":599,"country":129,"status":967,"trialStatus":43,"decision":72,"assessmentOutcome":586},"event:597b5ae248c58a2b8fbbef4b",{"id":1735,"studyId":1215,"euct":1216,"type":1433,"date":1239,"timeBasis":1430,"applicationBusinessKey":384,"country":145,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:47073c2074d0779589eb6404",{"id":1737,"studyId":276,"euct":277,"type":1429,"date":299,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:d57e7a6c1fea4203a617f3ad",{"id":1739,"studyId":561,"euct":562,"type":1429,"date":674,"timeBasis":1430,"applicationBusinessKey":602,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:05663450fab2348b85cbb961",{"id":1741,"studyId":1268,"euct":1269,"type":1429,"date":1308,"timeBasis":1430,"applicationBusinessKey":384,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:cba596b73028fb6d5224fa36",{"id":1743,"studyId":1215,"euct":1216,"type":1436,"date":1253,"timeBasis":1430,"applicationBusinessKey":384,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:bf195b85e10643d59fd52ca0",{"id":1745,"studyId":1215,"euct":1216,"type":1439,"date":1233,"timeBasis":1430,"applicationBusinessKey":384,"country":145,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:105fc8975c1da81ee9467539",{"id":1747,"studyId":1079,"euct":1080,"type":1429,"date":1153,"timeBasis":1430,"applicationBusinessKey":515,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:62477b8d9d373ea543684d5b",{"id":1749,"studyId":1079,"euct":1080,"type":1433,"date":1108,"timeBasis":1430,"applicationBusinessKey":515,"country":66,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:30849f71c3a9238015847185",{"id":1751,"studyId":1079,"euct":1080,"type":1436,"date":1108,"timeBasis":1430,"applicationBusinessKey":515,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:ee7aef7cec7961925035ed0d",{"id":1753,"studyId":1079,"euct":1080,"type":1439,"date":1119,"timeBasis":1430,"applicationBusinessKey":515,"country":66,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:026cc78958eb648af8530c6f",{"id":1755,"studyId":561,"euct":562,"type":1433,"date":603,"timeBasis":1430,"applicationBusinessKey":602,"country":582,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73},"event:9f62f4ed10115e62f0b55982",{"id":1757,"studyId":561,"euct":562,"type":1436,"date":675,"timeBasis":1430,"applicationBusinessKey":602,"country":45,"status":43,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:e3b0757fd162090b6b7ad195",{"id":1759,"studyId":561,"euct":562,"type":1439,"date":583,"timeBasis":1430,"applicationBusinessKey":602,"country":582,"status":43,"trialStatus":566,"decision":72,"assessmentOutcome":73},"event:99d3d97732f3bfa5bb587a08",{"id":1761,"studyId":893,"euct":894,"type":1436,"date":929,"timeBasis":1430,"applicationBusinessKey":80,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:51b0ef047d2428c6324012ce",{"id":1763,"studyId":893,"euct":894,"type":1429,"date":929,"timeBasis":1430,"applicationBusinessKey":80,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:59ca06bbfa754e64e59d063f",{"id":1765,"studyId":893,"euct":894,"type":1439,"date":913,"timeBasis":1430,"applicationBusinessKey":80,"country":145,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45},"event:8c656bab4bcfbae879502dd8",{"id":1767,"studyId":215,"euct":216,"type":1429,"date":261,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:2de5c06f7780401f2f2ff132",{"id":1769,"studyId":276,"euct":277,"type":1433,"date":293,"timeBasis":1430,"applicationBusinessKey":70,"country":158,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:8681d001bfec03da832f2620",{"id":1771,"studyId":276,"euct":277,"type":1436,"date":294,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:39f0590a6d00b7bd6c9b9d7d",{"id":1773,"studyId":276,"euct":277,"type":1439,"date":279,"timeBasis":1430,"applicationBusinessKey":70,"country":158,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:375dbac55477bd282cf1fda5",{"id":1775,"studyId":694,"euct":695,"type":1429,"date":579,"timeBasis":1430,"applicationBusinessKey":736,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:e0161b8829810e44258b5064",{"id":1777,"studyId":804,"euct":805,"type":1429,"date":249,"timeBasis":1430,"applicationBusinessKey":384,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:269abe4f5b0e8ec604a4128e",{"id":1779,"studyId":1268,"euct":1269,"type":1433,"date":1292,"timeBasis":1430,"applicationBusinessKey":384,"country":145,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:964bede243ad1042839c6842",{"id":1781,"studyId":1268,"euct":1269,"type":1436,"date":1309,"timeBasis":1430,"applicationBusinessKey":384,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:795ad5bb2b44fa4a0b042b5f",{"id":1783,"studyId":1268,"euct":1269,"type":1439,"date":1295,"timeBasis":1430,"applicationBusinessKey":384,"country":145,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:11072d9ddda1861e0d0ee82d",{"id":1785,"studyId":1268,"euct":1269,"type":1436,"date":1316,"timeBasis":1430,"applicationBusinessKey":80,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:49062ac11f11a3c620838206",{"id":1787,"studyId":1268,"euct":1269,"type":1429,"date":1316,"timeBasis":1430,"applicationBusinessKey":80,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:ac3ae2ad54d258f0f949b1a1",{"id":1789,"studyId":1268,"euct":1269,"type":1439,"date":1297,"timeBasis":1430,"applicationBusinessKey":80,"country":145,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45},"event:50f7f50be0ba1e09fb65a956",{"id":1791,"studyId":694,"euct":695,"type":1436,"date":787,"timeBasis":1430,"applicationBusinessKey":736,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:26c3de9a7ae60434ce6905e2",{"id":1793,"studyId":694,"euct":695,"type":1439,"date":737,"timeBasis":1430,"applicationBusinessKey":736,"country":139,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45},"event:ba1da3106abaa4de67fd9139",{"id":1795,"studyId":804,"euct":805,"type":1433,"date":826,"timeBasis":1430,"applicationBusinessKey":384,"country":139,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:dc1d7ca056f93b66481bb53a",{"id":1797,"studyId":804,"euct":805,"type":1436,"date":838,"timeBasis":1430,"applicationBusinessKey":384,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:e177a1d21222d731f6786f3e",{"id":1799,"studyId":804,"euct":805,"type":1439,"date":821,"timeBasis":1430,"applicationBusinessKey":384,"country":139,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:8210a8a402dba02c0563a5b2",{"id":1801,"studyId":357,"euct":358,"type":1429,"date":412,"timeBasis":1430,"applicationBusinessKey":388,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:a21f523bce66ed2394e51649",{"id":1803,"studyId":215,"euct":216,"type":1433,"date":255,"timeBasis":1430,"applicationBusinessKey":70,"country":145,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:c43ae1411205b01c40e30b4e",{"id":1805,"studyId":215,"euct":216,"type":1436,"date":256,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:f9cf93d6f14e23a6a0812bd9",{"id":1807,"studyId":215,"euct":216,"type":1439,"date":221,"timeBasis":1430,"applicationBusinessKey":70,"country":145,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:e1081fea0bd3f5a38a4b1d85",{"id":1809,"studyId":357,"euct":358,"type":1433,"date":389,"timeBasis":1430,"applicationBusinessKey":388,"country":145,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:b5c89f24733d87970ae85f51",{"id":1811,"studyId":357,"euct":358,"type":1436,"date":413,"timeBasis":1430,"applicationBusinessKey":388,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:272499e91d3cf0b09b10aa9a",{"id":1813,"studyId":357,"euct":358,"type":1439,"date":378,"timeBasis":1430,"applicationBusinessKey":388,"country":145,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:b26c45283613c34808186448",{"id":1815,"studyId":489,"euct":490,"type":1429,"date":546,"timeBasis":1430,"applicationBusinessKey":515,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:bfc1854d4cc170ed42496869",{"id":1817,"studyId":489,"euct":490,"type":1436,"date":186,"timeBasis":1430,"applicationBusinessKey":515,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:43099f0844731d4440e50d52",{"id":1819,"studyId":108,"euct":109,"type":1429,"date":186,"timeBasis":1430,"applicationBusinessKey":133,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:b046d812673734762f30ed04",{"id":1821,"studyId":489,"euct":490,"type":1433,"date":186,"timeBasis":1430,"applicationBusinessKey":515,"country":158,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:bd92c4a37b8ad290f4672503",{"id":1823,"studyId":489,"euct":490,"type":1439,"date":508,"timeBasis":1430,"applicationBusinessKey":515,"country":158,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:6376199b340600231d787d2b",{"id":1825,"studyId":1174,"euct":1175,"type":1429,"date":1199,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:11a73a15d5d311fc115648e5",{"id":1827,"studyId":38,"euct":39,"type":1429,"date":86,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:b26f994fd1d0c9f5cd6d29f0",{"id":1829,"studyId":1268,"euct":1269,"type":1436,"date":62,"timeBasis":1430,"applicationBusinessKey":1290,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:63f68b64000dfef0e33cc768",{"id":1831,"studyId":1268,"euct":1269,"type":1429,"date":62,"timeBasis":1430,"applicationBusinessKey":1290,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:b00037796b3e2c34f9c75917",{"id":1833,"studyId":1268,"euct":1269,"type":1439,"date":1285,"timeBasis":1430,"applicationBusinessKey":1290,"country":145,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45},"event:1348fb054cb8818c7f75e857",{"id":1835,"studyId":1079,"euct":1080,"type":1429,"date":1160,"timeBasis":1430,"applicationBusinessKey":599,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:0fbe382a5f935827eac40bd4",{"id":1837,"studyId":944,"euct":945,"type":1436,"date":1023,"timeBasis":1430,"applicationBusinessKey":978,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:128209e96c19efb54cc5ae10",{"id":1839,"studyId":944,"euct":945,"type":1429,"date":1023,"timeBasis":1430,"applicationBusinessKey":978,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:32fbdb30f60c51d1b4973ca3",{"id":1841,"studyId":944,"euct":945,"type":1439,"date":979,"timeBasis":1430,"applicationBusinessKey":978,"country":129,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45},"event:614d22cfa38d9ceeee425669",{"id":1843,"studyId":108,"euct":109,"type":1433,"date":181,"timeBasis":1430,"applicationBusinessKey":133,"country":177,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:a9c89a179704412e429b8079",{"id":1845,"studyId":1174,"euct":1175,"type":1433,"date":1193,"timeBasis":1430,"applicationBusinessKey":70,"country":145,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:606f8ac65f0512f0f8624949",{"id":1847,"studyId":1174,"euct":1175,"type":1436,"date":1194,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:20f8dbe4d18fd9b2468e5050",{"id":1849,"studyId":1174,"euct":1175,"type":1439,"date":1178,"timeBasis":1430,"applicationBusinessKey":70,"country":145,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:39d35fce2a4167c04dd60ed3",{"id":1851,"studyId":108,"euct":109,"type":1433,"date":149,"timeBasis":1430,"applicationBusinessKey":133,"country":145,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:ff9c6fe7fa6ae9bca607721b",{"id":1853,"studyId":108,"euct":109,"type":1433,"date":174,"timeBasis":1430,"applicationBusinessKey":133,"country":66,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:ea698b6cabcafcade3ddfdd5",{"id":1855,"studyId":108,"euct":109,"type":1433,"date":135,"timeBasis":1430,"applicationBusinessKey":133,"country":158,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:09a4f1082715b70ea4141500",{"id":1857,"studyId":108,"euct":109,"type":1433,"date":135,"timeBasis":1430,"applicationBusinessKey":133,"country":129,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:1dc2cecef2125fbd5801e482",{"id":1859,"studyId":108,"euct":109,"type":1433,"date":125,"timeBasis":1430,"applicationBusinessKey":133,"country":164,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:14665ddc0211db5b7292fb0b",{"id":1861,"studyId":108,"euct":109,"type":1433,"date":125,"timeBasis":1430,"applicationBusinessKey":133,"country":153,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:6ec7496377f7ea2e436f135e",{"id":1863,"studyId":108,"euct":109,"type":1433,"date":125,"timeBasis":1430,"applicationBusinessKey":133,"country":139,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:f24671870405576741bd1d9b",{"id":1865,"studyId":108,"euct":109,"type":1436,"date":136,"timeBasis":1430,"applicationBusinessKey":133,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:776b3e3dd4a9ca6ca0107dbd",{"id":1867,"studyId":108,"euct":109,"type":1439,"date":113,"timeBasis":1430,"applicationBusinessKey":133,"country":153,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:db74f1cb246346688491cdfd",{"id":1869,"studyId":108,"euct":109,"type":1439,"date":178,"timeBasis":1430,"applicationBusinessKey":133,"country":177,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:7df7c8f3403e03d195b85de8",{"id":1871,"studyId":108,"euct":109,"type":1439,"date":140,"timeBasis":1430,"applicationBusinessKey":133,"country":139,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:db5a15c38f43f515d27d871f",{"id":1873,"studyId":108,"euct":109,"type":1439,"date":130,"timeBasis":1430,"applicationBusinessKey":133,"country":129,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:9063f7e6fa4203086534e2c8",{"id":1875,"studyId":108,"euct":109,"type":1439,"date":171,"timeBasis":1430,"applicationBusinessKey":133,"country":66,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:dcf0a6637024342606c762a2",{"id":1877,"studyId":108,"euct":109,"type":1439,"date":159,"timeBasis":1430,"applicationBusinessKey":133,"country":158,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:a947ff3b91b486ff3c20f31a",{"id":1879,"studyId":108,"euct":109,"type":1439,"date":146,"timeBasis":1430,"applicationBusinessKey":133,"country":145,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:afa0e4cc3ebb2380fa593532",{"id":1881,"studyId":108,"euct":109,"type":1439,"date":165,"timeBasis":1430,"applicationBusinessKey":133,"country":164,"status":43,"trialStatus":43,"decision":134,"assessmentOutcome":73},"event:2f5fee4dedce276a4f8203a3",{"id":1883,"studyId":1079,"euct":1080,"type":1436,"date":1110,"timeBasis":1430,"applicationBusinessKey":599,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:10e8e29d1d1b62574755a6bb",{"id":1885,"studyId":1079,"euct":1080,"type":1433,"date":1110,"timeBasis":1430,"applicationBusinessKey":599,"country":66,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:1559de82bbe900fdb8b0bc82",{"id":1887,"studyId":1079,"euct":1080,"type":1439,"date":1098,"timeBasis":1430,"applicationBusinessKey":599,"country":66,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:1a3a824df5416e9534402719",{"id":1889,"studyId":38,"euct":39,"type":1433,"date":74,"timeBasis":1430,"applicationBusinessKey":70,"country":66,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:77dcc198c36f736adc742939",{"id":1891,"studyId":38,"euct":39,"type":1436,"date":75,"timeBasis":1430,"applicationBusinessKey":70,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:0737a61c1bf424872ba3f48d",{"id":1893,"studyId":38,"euct":39,"type":1439,"date":46,"timeBasis":1430,"applicationBusinessKey":70,"country":66,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":73},"event:fb256348fa07584c386db38f",{"id":1895,"studyId":38,"euct":39,"type":1429,"date":93,"timeBasis":1430,"applicationBusinessKey":80,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:0701670ff4ebcbec51ba605c",{"id":1897,"studyId":38,"euct":39,"type":1436,"date":93,"timeBasis":1430,"applicationBusinessKey":80,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:0efaeb6c6e52aa198ad60cda",{"id":1899,"studyId":38,"euct":39,"type":1439,"date":82,"timeBasis":1430,"applicationBusinessKey":80,"country":66,"status":43,"trialStatus":43,"decision":72,"assessmentOutcome":45},"event:a3a5d0e2e0a9fd29e8e29465",{"id":1901,"studyId":804,"euct":805,"type":1902,"date":6,"timeBasis":1903,"applicationBusinessKey":45,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:310c7f0c58e132416ca29174","trial_status_observed","collector_observation",{"id":1905,"studyId":1268,"euct":1269,"type":1902,"date":6,"timeBasis":1903,"applicationBusinessKey":45,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:38be5b81a615c7d5b6f7e330",{"id":1907,"studyId":434,"euct":435,"type":1902,"date":6,"timeBasis":1903,"applicationBusinessKey":45,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:3e208003ba627e22ccd29349",{"id":1909,"studyId":1174,"euct":1175,"type":1902,"date":6,"timeBasis":1903,"applicationBusinessKey":45,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:3fc7e4257bb3f0ad2e2ddbc4",{"id":1911,"studyId":314,"euct":315,"type":1902,"date":6,"timeBasis":1903,"applicationBusinessKey":45,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:513e20696d7bee467f9d52b0",{"id":1913,"studyId":561,"euct":562,"type":1902,"date":6,"timeBasis":1903,"applicationBusinessKey":45,"country":45,"status":566,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:6400fe423a5e952a3c6a16d1",{"id":1915,"studyId":276,"euct":277,"type":1902,"date":6,"timeBasis":1903,"applicationBusinessKey":45,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:6dd6480cfb93330b23af7ed9",{"id":1917,"studyId":944,"euct":945,"type":1902,"date":6,"timeBasis":1903,"applicationBusinessKey":45,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:6eded49f4265b4568e22ea89",{"id":1919,"studyId":1079,"euct":1080,"type":1902,"date":6,"timeBasis":1903,"applicationBusinessKey":45,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:77e5e5efd945516f664981d0",{"id":1921,"studyId":38,"euct":39,"type":1902,"date":6,"timeBasis":1903,"applicationBusinessKey":45,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:9650edf977bf66018f52af54",{"id":1923,"studyId":694,"euct":695,"type":1902,"date":6,"timeBasis":1903,"applicationBusinessKey":45,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:b3e3bc1f458139766682e902",{"id":1925,"studyId":108,"euct":109,"type":1902,"date":6,"timeBasis":1903,"applicationBusinessKey":45,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:b57b52c7bf7cbfcaadb047a2",{"id":1927,"studyId":1037,"euct":1038,"type":1902,"date":6,"timeBasis":1903,"applicationBusinessKey":45,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:c392559e5de84e46230836af",{"id":1929,"studyId":215,"euct":216,"type":1902,"date":6,"timeBasis":1903,"applicationBusinessKey":45,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:d103ef6d23b0db791be89546",{"id":1931,"studyId":852,"euct":853,"type":1902,"date":6,"timeBasis":1903,"applicationBusinessKey":45,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:dbe86139ca2b2fd8e2905fc6",{"id":1933,"studyId":357,"euct":358,"type":1902,"date":6,"timeBasis":1903,"applicationBusinessKey":45,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:f512999b11ad46200d36d375",{"id":1935,"studyId":1336,"euct":1337,"type":1902,"date":6,"timeBasis":1903,"applicationBusinessKey":45,"country":45,"status":566,"trialStatus":566,"decision":45,"assessmentOutcome":45},"event:f597b8c3dcef6ecb19e814bf",{"id":1937,"studyId":1215,"euct":1216,"type":1902,"date":6,"timeBasis":1903,"applicationBusinessKey":45,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:fa1b8d8371fc9cef7e64ed1c",{"id":1939,"studyId":489,"euct":490,"type":1902,"date":6,"timeBasis":1903,"applicationBusinessKey":45,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:fd119f12e0f28f3a90a7990a",{"id":1941,"studyId":893,"euct":894,"type":1902,"date":6,"timeBasis":1903,"applicationBusinessKey":45,"country":45,"status":43,"trialStatus":43,"decision":45,"assessmentOutcome":45},"event:fead986a35e2eacf74b72cd5",{"timeBasis":1903,"sourceChangeDatesAvailable":20,"archiveVerified":12,"events":1943},[1944,1951,1959,1971],{"id":1945,"type":1946,"observedAt":24,"timeBasis":1903,"materialFingerprint":1947,"addedStudyIds":1948,"changedStudyIds":1949,"notObservedStudyIds":1950},"observation:936442d1af83aecb0f282fa1","baseline_observed","76a2656188db9b4ed7e5188831bcb5aea24a2f78082812b318588815eb2e1d5c",[38,108,215,276,314,357,434,489,561,694,804,852,893,944,1037,1079,1174,1215,1268,1336],[],[],{"id":1952,"type":1953,"sourceType":1946,"observedAt":1954,"timeBasis":1903,"materialFingerprint":45,"sourceRevision":4,"trialCount":23,"fields":1955,"addedStudyIds":1956,"changedStudyIds":1957,"notObservedStudyIds":1958},"archive:event-8c4c63fd129e23204a023234","archive_baseline_observed","2026-07-23T13:03:56.000Z",[],[],[],[],{"id":1960,"type":1961,"sourceType":1961,"observedAt":1962,"timeBasis":1903,"materialFingerprint":45,"sourceRevision":1963,"trialCount":45,"fields":1964,"addedStudyIds":1968,"changedStudyIds":1969,"notObservedStudyIds":1970},"archive:event-2fe278db827682f37a5d0bb3","trial_changed","2026-07-29T02:29:00.000Z",7,[1965,1966,1967],"applications","publishDate","search",[],[38],[],{"id":1972,"type":1961,"sourceType":1961,"observedAt":1973,"timeBasis":1903,"materialFingerprint":45,"sourceRevision":1974,"trialCount":45,"fields":1975,"addedStudyIds":1980,"changedStudyIds":1981,"notObservedStudyIds":1982},"archive:event-f9432636e8148792c54ad3a7","2026-08-05T02:29:00.000Z",14,[1976,1977,1978,1966,1967,1979],"countries","events","publicStatusCode","startDateEU",[],[108],[],{"selection":1984,"identity":1985,"privacy":1986,"histories":1987,"limits":1988},"Closed registry of 20 verified EUCT identifiers with exact AI-term evidence in reviewed CTIS public scientific fields.","EUCT number only. Similar names, sponsors and titles are never merged.","The bootstrap sanitizes the in-memory CTIS response immediately. Raw records, contacts, addresses, telephone numbers and email addresses are never written.","Application and country status history reproduces allowlisted CTIS public record fields. Collector observation events are kept separately.","Presence in this dataset does not establish efficacy, safety, causality, regulatory compliance or a material role of AI in the intervention.",[1990,1992,1994,1996,1998,2000,2002,2004,2006,2008,2010,2012,2014,2016,2018,2020,2022,2024,2026,2028],{"id":38,"euct":39,"slug":39,"dateModified":7,"route":1991},"\u002Ftools\u002Fki-studienmonitor\u002Fstudie\u002F2026-525620-23-00\u002F",{"id":108,"euct":109,"slug":109,"dateModified":7,"route":1993},"\u002Ftools\u002Fki-studienmonitor\u002Fstudie\u002F2023-505575-69-01\u002F",{"id":215,"euct":216,"slug":216,"dateModified":8,"route":1995},"\u002Ftools\u002Fki-studienmonitor\u002Fstudie\u002F2025-523264-21-00\u002F",{"id":276,"euct":277,"slug":277,"dateModified":8,"route":1997},"\u002Ftools\u002Fki-studienmonitor\u002Fstudie\u002F2025-521385-10-00\u002F",{"id":314,"euct":315,"slug":315,"dateModified":8,"route":1999},"\u002Ftools\u002Fki-studienmonitor\u002Fstudie\u002F2024-518482-99-01\u002F",{"id":357,"euct":358,"slug":358,"dateModified":8,"route":2001},"\u002Ftools\u002Fki-studienmonitor\u002Fstudie\u002F2024-510718-34-00\u002F",{"id":434,"euct":435,"slug":435,"dateModified":8,"route":2003},"\u002Ftools\u002Fki-studienmonitor\u002Fstudie\u002F2024-510707-11-00\u002F",{"id":489,"euct":490,"slug":490,"dateModified":8,"route":2005},"\u002Ftools\u002Fki-studienmonitor\u002Fstudie\u002F2023-505430-10-00\u002F",{"id":561,"euct":562,"slug":562,"dateModified":8,"route":2007},"\u002Ftools\u002Fki-studienmonitor\u002Fstudie\u002F2022-502338-20-00\u002F",{"id":694,"euct":695,"slug":695,"dateModified":8,"route":2009},"\u002Ftools\u002Fki-studienmonitor\u002Fstudie\u002F2022-500596-32-00\u002F",{"id":804,"euct":805,"slug":805,"dateModified":8,"route":2011},"\u002Ftools\u002Fki-studienmonitor\u002Fstudie\u002F2024-520288-15-00\u002F",{"id":852,"euct":853,"slug":853,"dateModified":8,"route":2013},"\u002Ftools\u002Fki-studienmonitor\u002Fstudie\u002F2024-518494-34-00\u002F",{"id":893,"euct":894,"slug":894,"dateModified":8,"route":2015},"\u002Ftools\u002Fki-studienmonitor\u002Fstudie\u002F2024-516022-63-00\u002F",{"id":944,"euct":945,"slug":945,"dateModified":8,"route":2017},"\u002Ftools\u002Fki-studienmonitor\u002Fstudie\u002F2023-503617-30-02\u002F",{"id":1037,"euct":1038,"slug":1038,"dateModified":8,"route":2019},"\u002Ftools\u002Fki-studienmonitor\u002Fstudie\u002F2022-501892-14-00\u002F",{"id":1079,"euct":1080,"slug":1080,"dateModified":8,"route":2021},"\u002Ftools\u002Fki-studienmonitor\u002Fstudie\u002F2023-508316-27-00\u002F",{"id":1174,"euct":1175,"slug":1175,"dateModified":8,"route":2023},"\u002Ftools\u002Fki-studienmonitor\u002Fstudie\u002F2025-525008-12-00\u002F",{"id":1215,"euct":1216,"slug":1216,"dateModified":8,"route":2025},"\u002Ftools\u002Fki-studienmonitor\u002Fstudie\u002F2024-513248-27-00\u002F",{"id":1268,"euct":1269,"slug":1269,"dateModified":8,"route":2027},"\u002Ftools\u002Fki-studienmonitor\u002Fstudie\u002F2023-510304-53-00\u002F",{"id":1336,"euct":1337,"slug":1337,"dateModified":8,"route":2029},"\u002Ftools\u002Fki-studienmonitor\u002Fstudie\u002F2024-513123-17-00\u002F",{"json":2031,"studiesCsv":2032,"evidenceCsv":2033,"eventsCsv":2034,"observationsCsv":2035,"methodologyJson":2036,"collectionJson":2037,"atom":2038},"\u002Fdata\u002Fki-studienmonitor\u002Findex.json","\u002Fdata\u002Fki-studienmonitor\u002Fstudies.csv","\u002Fdata\u002Fki-studienmonitor\u002Fevidence.csv","\u002Fdata\u002Fki-studienmonitor\u002Fevents.csv","\u002Fdata\u002Fki-studienmonitor\u002Fobservations.csv","\u002Fdata\u002Fki-studienmonitor\u002Fmethodology.json","\u002Fdata\u002Fki-studienmonitor\u002Fcollection.json","\u002Fdata\u002Fki-studienmonitor\u002Ffeed.atom",1786545403316]